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ABSTRACT
DEVELOPMENT OF A WEB APPLICATION/DATABASE FOR THE
INTEGRATIVE ANALYSIS OF microRNA EXPRESSION
PATTERNS
Koray Doğan Kaya
Ph.D. Thesis in Molecular Biology and Genetics
Advisor: Assist. Prof. Dr. Özlen Konu
August 2011, 125 pages
microRNAs, small non-coding RNA molecules with important roles in
cellular machinery, target mRNAs for silencing by binding generally to their 3’ UTR
sequences via partial base complementation. Thus, microRNAs with similar
sequences also might exhibit expression and/or functional similarities. In this study, a
modular tool, mESAdb (http://konulab.fen.bilkent.edu.tr/mirna/), was developed
allowing for multivariate analysis of sequences and expression of microRNAs from
multiple taxa. Its framework comprises PHP, JavaScript, packages in the R language,
and a database storing mature microRNA sequences along with microRNA targets
and selected expression data sets for human, mouse and zebrafish. mESAdb allows
for: (i) mining of microRNA expression data sets for subsets of microRNAs selected
manually or by a sequence motif; (ii) pair-wise multivariate analysis of expression
data sets within and between taxa; and (iii) association of microRNA subsets with
annotation databases, HuGE Navigator, KEGG and GO. mESAdb also permits user
specified dataset upload for these analyses. Herein, utility of mESAdb was illustrated
using different datasets and case studies. First, it was shown that microRNAs
carrying the embryonic stem cell specific seed sequence, ‘AAGTGC’, were able to
discriminate between normal and tumor tissues from hepatocellular carcinoma
patients using dataset GSE10694. Second, mRNA targets of a set of liver specific
microRNAs were annotated with human diseases based on HuGE Navigator. Third,
the similarity between mouse and human tissue specificity of a given set of
iv
microRNAs was demonstrated. Forth, CHRNA5 targeting microRNAs were
associated with estrogen receptor status in breast cancer using dataset GSE15885.
Finally, a related tool under development for mRNA arrays planned for integration
with mESAdb was presented.
Keywords: mESAdb, database, R, microRNA, sequence, expression data sets,
data mining, multivariate analysis, annotation databases, HuGE, KEGG, GO,
CHRNA5, estrogen receptor, hepatocellular carcinoma and breast cancer..
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ÖZET
MikroRNA ĐFADE ÖRÜNTÜLERĐNĐN BÜTÜNLEŞTĐRĐCĐ ANALĐZĐ
ĐÇĐN AĞ ARACI/VERĐTABANI GELĐŞTĐRĐLMESĐ
Koray Doğan Kaya
Doktora Tezi, Moleküler Biyoloji ve Genetik
Danışman: Yrd. Doç. Dr. Özlen Konu
Ağustos 2011, 125 sayfa
mikroRNA’lar protein kodlamayan, küçük ve hücrelerdeki mekanizmalarda
önemli rolleri olan RNA molekülleri olup genellikle mesajcı RNA’ların protein
kodlamayan 3’ bölgesine kısmi baz eşlemesi yoluyla bağlanır ve onların proteine
çevrilmesine engel olur. Bu nedenle dizilerinde benzerlik gösteren mikroRNA’lar
fonksiyonel ve/veya ifade düzeyi olarak da benzerlik gösterebilirler. Bu çalışmada,
değişik taksonlardan gelen mikroRNA’ların dizi ve ifadelerinin çok değişkenli
analizlerini yapmak için modüler bir araç/veritabanı olan mESAdb
(http://konulab.fen.bilkent.edu.tr/mirna/) geliştirilmiştir. Omurgası, PHP, JavaScript,
R paketleri ve ağırlıklı olarak, insan, fare ve zebrabalığı için, mikroRNA’ların olgun
dizilerini, onların hedef genlerini ve seçilmiş mikrodizin veri setlerini depolayan bir
veritabanından oluşur. mESAdb üç önemli kullanıma olanak verir: (i) dizi motifi
veya seçilen mikroRNA’lar ile ifade veri madenciliği; (ii) taxonlar arası ikili veri
setlerinin çok değişkenli analizi; (iii) mikroRNA gruplarının referans isimlendirme
veri tabanları, örneğin HuGE, KEGG ve GO, ile ilişkilendirilmesi. mESAdb
kullanıcıların özgün ifade veri setlerini yükleyip analiz etmelerine de izin
vermektedir. Bu çalışmada, mESAdb kullanımı değişik veri setleri ve örnek
durumlar ile anlatılmıştır. Đlk olarak, embriyoya özgü kök hücre mikroRNA çekirdek
dizisi AAGTGC’yi taşıyan mikroRNA’ların, GSE10694 veri seti kullanılarak,
hepatosellüler karsinom hastalarından alınan tümörlü ve normal karaciğer dokularını
ayrıştırabildiği gösterildi. Đkinci olarak, karaciğere özgün bir gurup mikroRNA’nın
hedef aldığı mRNA’lar HuGE Navigator veri tabanı esas alınarak insan hastalıklarına
ait referans terimlerle ilişkilendirildi. Üçüncü olarak, seçilen bir gurup mikroRNA,
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insan ve fare için doku iyeliği bakımından karşılaştırıldı. Dördüncü olarak,
GSE15885 veri-seti kullanılarak, CHRNA5 genini hedef alan mikroRNA’lar östrojen
duyargaç (ER) gen ifadesi bakımından farklılık gösteren meme kanseri örnekleri ile
ilişkilendirildi. Son olarak, mESAdb ile benzer omurga kullanılarak mRNA dizin
çalışmalarının analizi için tasarlanan ve yapımı devam eden bir başka çalışma
tanıtıldı.
Anahtar Sözcükler: mESAdb, veritabanı, R, mikroRNA, dizi, gen ifade very setleri,
very madenciliği, çok değişkenli analiz, referans isimlendirme veritabanları, HuGE,
KEGG, GO, CHRNA5, östrojen duyargaçı, hepatosellüler karsinom and meme
kanseri.
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CHAPTER 1:INTRODUCTION
1.1 MICRORNAS
In 1993, Victor Ambross and colleagues announced that the transcript of the
gene called lin4, regulating the timing of C. elegans larval development, did not code
for a protein. Instead, this gene produced two short RNAs, 22 and 61 nucleotides in
length, respectively (Lee, Feinbaum et al. 1993). This aforementioned gene has been
the founding member of a non-coding RNA gene family, called microRNAs (Bartel
2004). The second member of this large RNA family is Let-7, that also has been
discovered in C. elegans and was found to regulate the transition from late larval to
adult stage in a similar way as lin-4 regulated the timing between the first and the
second larval stages of worm development (Reinhart, Slack et al. 2000; Slack,
Basson et al. 2000).
Mature microRNAs are small (19–22 nt) RNAs that play crucial roles in
many cellular processes via targeting mRNAs for translational repression or cleavage
thus regulating gene expression (Bartel 2004). MicroRNAs, through their compatible
5'-seed sequences, exert regulatory functions primarily on the 3'-untranslated regions
(UTRs) of targeted mRNAs (Lewis, Burge et al. 2005; Grimson, Farh et al. 2007;
Iwama, Masaki et al. 2007). They are functional in crucial roles, such as
development (Lee, Feinbaum et al. 1993; Boutet, Vazquez et al. 2003; Krichevsky,
King et al. 2003; Alvarez-Garcia and Miska 2005; Shi and Jin 2009), apoptosis
(Brennecke, Hipfner et al. 2003; Bartel 2004; Lynam-Lennon, Maher et al. 2009),
differentiation (Kawasaki and Taira 2003; Kawasaki and Taira 2003; Shi and Jin
2009) and metabolism (Xu, Vernooy et al. 2003; Jordan, Kruger et al. 2011; Tamasi,
Monostory et al. 2011) in animals. Evidence from earlier studies suggesting the
participation of microRNAs in a long list of human diseases, especially different
cancers, implies the importance of microRNAs (Alvarez-Garcia and Miska 2005;
Gregory and Shiekhattar 2005; Chhabra, Dubey et al. 2010; Wang, Yu et al. 2011;
Zhang, Yan et al. 2011).
According to miRBase (Ambros, Bartel et al. 2003; Griffiths-Jones 2004;
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Griffiths-Jones, Grocock et al. 2006; Griffiths-Jones, Saini et al. 2008; Kozomara
and Griffiths-Jones 2011) release 16, the number of discovered microRNA genes in
different organisms varies in range between 1 to 1048. The highest entry number
belongs to Homo sapiens in the range while the total number of microRNA entries
was 15172 in release of miRBase declared above.
However, the discovery of new microRNAs has slowed down. Although the
fact that mature sequences of a broad number of microRNAs are conserved among
different taxa (Wheeler, Heimberg et al. 2009), the wide range of microRNA entries
for different organisms in miRBase shows that new research technologies or broader
application of in silico methods (Li, Xu et al. 2010) are needed to balance the entry
numbers across organisms, which in turn will increase the pace of the novel
microRNA discovery. Indeed, next generation sequencing has now provided a lead
for novel microRNA discovery (Morin, O'Connor et al. 2008; Li, Chan et al. 2010).
1.2 MICRORNA TRANSCRIPTION,
MATURATION AND FUNCTION
Although some microRNA genes are located in intronic regions of protein
coding genes, many of them are intergenic (Lagos-Quintana, Rauhut et al. 2001; Lau,
Lim et al. 2001; Lee and Ambros 2001; Aravin, Lagos-Quintana et al. 2003; Lagos-
Quintana, Rauhut et al. 2003; Lai, Tomancak et al. 2003; Lim, Glasner et al. 2003;
Lim, Lau et al. 2003; Saini, Griffiths-Jones et al. 2007), meaning that they are in
between genes having their own transcription units (Lagos-Quintana, Rauhut et al.
2001; Lau, Lim et al. 2001; Lee and Ambros 2001).
microRNA genes can be located in an isolated fashion, as seen in human and
worm genomes (Lim, Glasner et al. 2003; Lim, Lau et al. 2003), or can be clustered
together producing multi-cistronic transcripts, as commonly seen in Drosophila
genome (Aravin, Lagos-Quintana et al. 2003).
The initial transcript forms of miRNAs are called primary microRNAs or pri-
miRNAs (Lee, Feinbaum et al. 1993). They are either a form of non-coding RNA
transcribed by RNA polymerase II or spliced intronic parts of pre-mRNAs (Krol,
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Loedige et al. 2010). Although some previous studies have attempted to derive a full
definition of primary transcript for a microRNA or a cluster of them from a non-
coding unit, it was not until 2007 that the boundaries of many pri-microRNAs in the
human genome have been precisely predicted (Saini, Griffiths-Jones et al. 2007).
The first step in the maturation of an approximately ~22nt RNA including the
5’ seed is splicing of the pri-miRNA by Drosha, an enzyme of RNase III type (Lee,
Ahn et al. 2003). This enzyme recognizes stem loop structure and cuts the long stem
and liberates a shorter, ~60-70 nt, hairpin, stem-loop molecule with 2-3 nt 3’
overhang (Basyuk, Suavet et al. 2003). Next, this molecule is transported to the
nucleus by exportin 5 (Yi, Qin et al. 2003; Lund, Guttinger et al. 2004). Another
RNase III enzyme, Dicer cuts the loop and produces a double stranded RNA with 2-3
nt 3’ overhang at both sides (Lee, Ahn et al. 2003). Afterwards, this dsRNA is
integrated into miRNA, mediated by RNA interference genes silencing complex,
miRISC (Bartel 2004; Meister and Tuschl 2004; Murchison and Hannon 2004; Krol,
Loedige et al. 2010). Here, the mature single stranded microRNA is partially
complementary to mRNA 3’UTR region of target gene and translation stop codons.
Even in some cases, de-adenylation occurs after targeted mRNA is degraded
(Giraldez, Mishima et al. 2006; Wu, Fan et al. 2006).
Intersetingly, few earlier studies that tried to report target:microRNA
relationship in depth have found that there are some among-species conserved
sequences in coding regions/ORFs (John, Enright et al. 2004; Lewis, Burge et al.
2005). Then in 2008, series of studies have been published reporting some
microRNAs might target coding regions. In early 2008, it has been experimentally
validated that p16 is a target of miR-24 as predicted by Miranda (Enright, John et al.
2003) and that miR-24 binds to regions both in 3’ UTR and the coding region of p16.
Later on, a study has announced that miR-126 represses Hoxa9 by binding an across
species conserved site at its Homeobox domain (Shen, Hu et al. 2008). Then, it was
reported that a conserved site (between nucleotides 2382 and 2412) existed on DNA
Methyl-transferase 3b (DNMT3b) mRNA as the target of miR-148 (Duursma, Kedde
et al. 2008). A comprehensive scanning study seeking for highly conserved
sequences in coding regions of all genes from 17 genomes showed that conserved
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sites were generally microRNA targets (Forman, Legesse-Miller et al. 2008). The
study has also solidly shown that let-7 family targets Dicer in three regions on its
coding sequence, forming a negative feedback loop on microRNA function (Forman,
Legesse-Miller et al. 2008). Apart from those which concentrated on conserved
sequences in coding regions, another study has shown that some microRNA targets
at exon-exon junctions seen in mouse are not conserved in humans (Tay, Zhang et al.
2008). However a relatively recent study claims that although the target sites for
microRNAs in the coding regions are functional, the effects are weaker compared to
the ones in the 3’ UTRs (Forman and Coller 2010).
1.2.1 microRNA expression profiles
The first evidence for the expression profile specificity of microRNAs for
different developmental stages and tissue types came from Northern blot studies
and/or cloning efforts followed by sequencing (Pasquinelli, Reinhart et al. 2000;
Lagos-Quintana, Rauhut et al. 2001; Lau, Lim et al. 2001; Lee and Ambros 2001;
Lagos-Quintana, Rauhut et al. 2002; Aravin, Lagos-Quintana et al. 2003;
Bashirullah, Pasquinelli et al. 2003; Basyuk, Suavet et al. 2003; Houbaviy, Murray et
al. 2003; Lagos-Quintana, Rauhut et al. 2003; Lai, Tomancak et al. 2003; Lim,
Glasner et al. 2003; Lim, Lau et al. 2003; Chen, Li et al. 2004). As expected, the first
remarkable scientific discoveries in regard to these specificities were about the
founding members of the microRNA gene family, lin4 and let-7. Accordingly, they
were found to be temporarily expressed in specific larval stages of C. elegans
(Pasquinelli, Reinhart et al. 2000; Lau, Lim et al. 2001; Lagos-Quintana, Rauhut et
al. 2002; Bashirullah, Pasquinelli et al. 2003; Lim, Lau et al. 2003).
After the discovery that microRNAs were not restricted to worms
(Pasquinelli, Reinhart et al. 2000), many new members discovered by cloning and
sequencing, also made their tissue specificity clear. Among those members were
miR-1, expressed mainly in the mammalian heart (Lee and Ambros 2001; Lagos-
Quintana, Rauhut et al. 2002), miR-122 which was specific to liver (Lagos-Quintana,
Rauhut et al. 2002), and miR-223 expressed in mouse granulocytes and macrophages
derived from bone marrow (Chen, Li et al. 2004). Another interesting discovery in
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this field has been that there were embryonic stem cell specific microRNAs, namely,
the miR-290/mir-295 cluster that was only expressed in mouse embryonic stem cells
(Houbaviy, Murray et al. 2003).
Those findings encouraged application of high throughput technologies to
explore, more broadly, such findings as mentioned above. Finally, a study has shown
that microRNAs have distinct expression patterns in different developmental stages
and regions of the mammalian brain by using an array expression technology
(Krichevsky, King et al. 2003). Based on further large-scale studies, microRNAs
were annotated for their specificity for particular tissues, developmental stages and/or
pathologies such as cancer (Houbaviy, Murray et al. 2003; Liu, Calin et al. 2004;
Sempere, Freemantle et al. 2004; Sun, Koo et al. 2004). These individual studies then
could be complied using meta-analysis methods: for example, Bargaje et al.
(Bargaje, Hariharan et al. 2010) compiled and normalized multiple data sets from
different sources to determine the tissue-specific and tissue-invariant consensus
expression profiles. Others have surveyed microRNA expression profiles in large
numbers of normal and cancerous tissues to decipher microRNA networks and
conserved expression clusters in disease (Navon, Wang et al. 2009). There also is
evidence suggesting that expression patterns of microRNAs are conserved at the
species level (Hertel, Lindemeyer et al. 2006). However, development of
database/tools that encompass tissue specific datasets with ability to analyze for a
specific set of microRNAs in a multivariate fashion is needed.
1.2.2 MicroRNA databases
In recent years, several databases and analysis tools have also been published
featuring high-throughput analysis results of microRNA sequence or expression.
Among these, miRBase functions as a central repository for microRNA genomics for
a variety of organisms and thus serves the community with up-to-date microRNA
sequence, chromosome location and transcript information (Ambros, Bartel et al.
2003; Griffiths-Jones 2004; Griffiths-Jones, Grocock et al. 2006; Griffiths-Jones,
Saini et al. 2008; Kozomara and Griffiths-Jones 2011). mSigDB, using motif lists
from Xie et al. (Xie, Lu et al. 2005), provides microRNA target gene lists that could
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be tested for enrichment with Gene Ontology (GO) functional terms, KEGG
signaling pathways or other gene lists (Subramanian, Kuehn et al. 2007). Similarly, a
manually curated database, called Mir2DiseaseBase, can be used for extracting
associations between diseases and microRNAs (Jiang, Wang et al. 2009). Most
recently, miRBridge has been developed to predict microRNA function and link
microRNAs with cellular pathways using network algorithms (Tsang, Ebert et al.
2010). Among the expression analysis focused databases, miRGator is a
comprehensive repository and analysis tool for microRNA expression, target and
ontology data providing a graphical transcriptional evaluation of selected microRNA
types for mice or humans (Nam, Kim et al. 2008). MicroRNA.org is another source
of microRNA expression and functional data for understanding microRNA
expression regulation through target prediction and examination of tissue transcript
abundance (Betel, Wilson et al. 2008).
1.2.2.1 miRBase
It is the pioneer database that provides all microRNA sequence data,
annotation and target information (Griffiths-Jones, Grocock et al. 2006). After the
sharp increase in the number of annotated miRNAs from a variety of organisms
(Pasquinelli, Reinhart et al. 2000; Lagos-Quintana, Rauhut et al. 2001; Lau, Lim et
al. 2001; Lee and Ambros 2001; Lagos-Quintana, Rauhut et al. 2002; Aravin, Lagos-
Quintana et al. 2003; Bashirullah, Pasquinelli et al. 2003; Basyuk, Suavet et al. 2003;
Houbaviy, Murray et al. 2003; Lagos-Quintana, Rauhut et al. 2003; Lai, Tomancak et
al. 2003; Lim, Glasner et al. 2003; Lim, Lau et al. 2003; Chen, Li et al. 2004), a
registry was needed to bring the existing data together and thus, the microRNA
registry was established (Griffiths-Jones 2004) according to the nomenclature
proposed by Ambros (Ambros, Bartel et al. 2003). Now it survives as miRBase
(Kozomara and Griffiths-Jones 2011).
In miRBase, the name of every microRNA entry in the database has a 3 or 4
letter prefix to specify their source species, e.g., ‘hsa’ for Homo sapiens, ‘mmu’ for
Mus musculus, etc.. After this prefix, ‘mir’ is used to annotate precursor hairpins
whereas ‘miR’ is assigned to mature sequences.
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1.2.3 microRNA - target relationsip
~20 bp Dicer cut output for pre-mRNA or mirton, pre-microRNA derived
from splicing events, interacts with mRNA in RISC complex (Krol, Loedige et al.
2010). Studies for determining the microRNA- target coupling features have shown
that conserved perfect ~6-8 base pair matchings (seed matches) at the 5’ end of
microRNAs are relaible recognition sequences for those interactions (Lewis, Shih et
al. 2003; Brennecke, Stark et al. 2005; Krek, Grun et al. 2005; Lewis, Burge et al.
2005; Lim, Lau et al. 2005; Jackson, Burchard et al. 2006). Seed sequences are
generally well conserved also between paralogues microRNAs. However, the
binding sites in microRNAs are classified into three types: (i) canonical, where 5’ is
dominant; (ii) seed only; and (iii) 3’ compensatory (Maziere and Enright 2007).
In the first one, perfect base pairing is observed at the seed region and perfect
match extends almost throughout the end of the 3’ site. In this type there is a classical
bulge in the middle. In the second type only the seed region has perfect match while
in the last one, seed region has mismatches and there are long strecthes pf perfect
matches towards the 3’end.
Another common rule that have been integrated to algorithms is the free
energy of microRNA:mRNA duplexes (Min and Yoon 2010). To calculate the free
energies of RNA foldings and base pairings some consensus programs have been
used such as Vienna Package (Wuchty, Fontana et al. 1999), RNAfold (Hofacker
2003) and Mfold (Mathews, Sabina et al. 1999). The free energy thresholds are
species specific (Watanabe, Tomita et al. 2007).
The core of microRNA target prediction methods relies on base paring
method defined by Lewis et al. (2003). There are other prediction algorithms (Min
and Yoon 2010) that use different features including evolutionary conservation
(Lewis, Shih et al. 2003; Grun, Wang et al. 2005), secondary structure of target
mRNA (Kertesz, Iovino et al. 2007; Long, Lee et al. 2007) and nucleotide
composition of target mRNA (Grimson, Farh et al. 2007). The current published
algorithms for predicting mRNA target sites have been well established (Watanabe,
Tomita et al. 2007; Alexiou, Maragkakis et al. 2009; Min and Yoon 2010), and some
essential ones are mentioned here.
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TargetScan (Lewis, Shih et al. 2003; Lewis, Burge et al. 2005; Grimson, Farh
et al. 2007; Friedman, Farh et al. 2009) considers 2nd to 8th nucleotides from 5’ end
of microRNA as seed sequence and seeks for perfect match for it in the target 3’
UTR. Then it expands the seed match for other part of microRNAs. Another feature
that the algorithm takes into account is free energy of binding of microRNA:miRNA
dublexes via RNAFold. TargetScanS is an improved version of TargetScan. The
differences between them are substantial ones. The most prominent difference
between them is that TargetScanS uses two or more species for sequence
conservation check instead of using thermodynamic stability check.
PicTar (Grun, Wang et al. 2005) focuses on multiple conserved seed
sequence binding sites across species co-regulated by multiple microRNAs instead of
looking for one seed sequence binding at an expected site on 3’ UTR. miRanda
(Enright, John et al. 2003) has originally been developed for fly microRNA targets,
was then applied to predict targets of microRNAs in human. Three features have
been used in the development of the algorithms. One is position-weighted base
complementation, the other one is free energies of RNA:RNA duplexes and final
feature is conservation of the target sites among 10 species. Further, a strict rule that
requires perfect complementation of the seed region has been added to the algorithm
(John, Enright et al. 2004). The targets predicted by this algorithm have been served
as a service called MicroCosm targets among EMBL-EBI tools. DIANA
(Maragkakis, Alexiou et al. 2009; Maragkakis, Reczko et al. 2009), uses a 38 bases
window in length and sliding it through 3’ UTR of the target. Then it selects the
binding with the lowest free energy. In contrast to others, it allows weak pairing for
seed regions.
Seed sequences and patterns on other parts of mature microRNAs also could
be important in functioning of microRNAs, hence, this may be seen as a reflection in
microRNA tissue specificity. All in all, a recent study has shown that unsupervised
clustering of microRNA seequence was successful in separation of invasive and non-
invasive breast cell carcinoma samples from different patients (Farazi, Horlings et al.
2011). In another study, a microRNA profiling has revealed a unique embryonic
stem cell signature dominated by a single seed sequence (Laurent, Chen et al. 2008).
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1.2.3.1 MicroCosm
MicroCosm (http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/)
(Enright, John et al. 2003; Griffiths-Jones 2004; Griffiths-Jones, Saini et al. 2008) is
a web tool for investigating microRNA targets in many species. The pipe for
reaching the targets uses two main resources, miRBase for microRNA sequences and
Ensembl (Flicek, Amode et al. 2011) for genomic sequences. The web resource
currently uses miRanda algorithm (Enright, John et al. 2003) to select potential target
sites. The current version (version 5) of MicroCosm uses dynamic programming for
aligning the seed sequence of microRNAs with the sites identified by miRanda. Each
alignment has a score between 0 and 100. The method applied uses strict rules. The
most determining one is allowance of only one mismatch between seed sequence and
the target sequence. Also the target site should be conserved in at least two species.
1.3 GO DATABASE
It is important to associate each microRNA and its target genes with a
functional term. This can be accomplished by using ontology databases. Gene
ontology is a set of controlled vocabulary that describes the role of genes in a cell. To
produce an agreed upon and stable vocabulary regarding attributes of genes, efforts
began as a collaborative work based on three databases, Saccharomyces Genome
Database (Cherry, Adler et al. 1998), Mouse Genome Database (Blake, Bult et al.
2011) and FlyBase (Tweedie, Ashburner et al. 2009) in 1998 (Ashburner, Ball et al.
2000; Lewis 2005). As databases arose to meet the requirement of integrating
information for different model organisms, scientists recognized that there was a
common problem of classification. For separate projects, functional classifications
had started individually, for example for E. coli, Monica Riley created one in 1993
(Riley 1993) and for the FlyBase, Ashburner created another one (Lewis 2005). The
Institute of Genomic Research (TIGR) (http://www.jcvi.org/) also created its own
functional classification system (Lewis 2005). At the end, Asburner proposed a
solution involving a simple hierarchical controlled vocabulary to define the common
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functional classification in bio-ontologies workshop, Intelligent Systems for
Molecular Biology (ISMB) international conference, Montreal. Although the
proposal had been dismissed by other participants, representatives of MGI, FlyBase
and SGD have agreed to use the same vocabulary (Lewis 2005). Then the Gene
Ontology Consortium was thus founded.
In GO, the vocabulary is grouped under three headings; cellular component,
molecular function and biological process. Within these headings, vocabularies have
a hierarchical relationship and are structured as directed acyclic graphs as seen in
Figure 1.3.1 (Ashburner, Ball et al. 2000; Binns, Dimmer et al. 2009). This means
that gene ontology entries can be queried at different levels from most general ones
to the most specific one, and any member of the vocabulary set can be a more
specific expansion of more than one general term. For example, GO:0016160 refers
to the GO term amylase activity, 206 genes have the same GO identity while gene
Amy1 from Mus musculus also has another GO term associated with it,
GO:0003824, i.e., catalytic activity. Catalytic activity is a more general term then
amylase activity. The relationship between these two terms can be seen in Figure
1.3.1.
Cellular Component is a part of a larger object in the cell. It may be an
anatomical structure such as nucleus or golgi apparatus. It also may define a gene
product group i.e., a protein dimer (Ashburner, Ball et al. 2000).
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Figure 1.3.1: A sample graph view presents the hierarchical relationship between GO terms.
The figure has been generated by QuickGO (Binns, Dimmer et al. 2009) linked in The Gene
Ontology Consortium web page.
A biological process refers to sequential events that are accomplished by one
or more ordered molecular functions. Signal transduction is an example in broad
scope whereas alpha-glucoside transport is an example of a more specific term
(Ashburner, Ball et al. 2000).
Molecular function ontology header describes a simple chemical activity such
as catalyzing or binding at molecular level. Generally, it comprises of actions taken
by one gene product, however it also includes the ones taken by assembled protein
complexes. Binding activity is an example of general term in this category however,
toll receptor binding is narrower one (Binns, Dimmer et al. 2009).
The Gene Ontology Consortium tool AMIGO gives associations between
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some microRNA genes and GO terms, however it is very limited. For example
although human genome has miR-15a as annotated gene, AMIGO does not show
Homo sapiens among the species filter when the microRNA is searched in it.
1.4 KEGG: KYOTO ENCYCLOPEDIA OF GENES
AND GENOMES
The KEGG database was launched as a project of Japanese Human Genome
Program in 1995 (Kanehisa 1997). From its foundation up to its August 2010 update
(Kanehisa, Goto et al. 2010) functions in the cell and organism behaviors has been
kept in the forms that computers could process them. Molecular networks forms are
the most popular ones among them. They are called as pathway maps. Another
important form is hierarchical lists called as BRITE functional lists. These structures
have been widely used for interpreting the large scale outputs of high-throughput
experimental technologies such as sequencing and microarray technologies.
The knowledge in KEGG Project has started to be focused on human diseases
and drugs. These new focuses have been integrated to the structures that are readily
could be processed by computers in such a way that human diseases have been
described as perturbed states of molecular systems that operate cells whereas drugs
have been defined as perturbants to them.
The latest report describing updates completed up to August 2010 says that
KEGG Project has been constructed from 16 main databases. However in the work
described in this thesis has used only KEGG PATHWAY database, manually drawn
pathways collection. Even the only pathways and diseases that could be matched
with genes have been used, among the complete pathways and diseases chemical
compounds and drugs also could be matched.
1.5 HUGE NAVIGATOR
A network called Human Genome Epidemiology Network (HuGENet) has
constructed and maintained a database collecting publications of population-based
epidemiological studies of human genes since 2001. Accordingly, HuGE Navigator
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(Yu, Gwinn et al. 2008) has emerged as a knowledge base comprising a database
integrating human genes, the human genome epidemiology associated with them and
a number of tools to make the database easier to use for interdisciplinary researchers.
Publications in the database are assigned to categories of study types such as
observational studies or meta-analysis and of data type such as gene-disease
association, gene-environment interaction or pharmacogenomics. Curators perform
assignments weekly and add new entries as a new collection of publications entered
into PubMed. Also, each publication is assigned a MeSH term (Medical Subject
Headings), a hierarchical ontology by the National Library of medicine for indexing
articles in MEDLINE, and to gene information from National Center for
Bioinformatics (NCBI) Entrez gene database (Maglott, Ostell et al. 2011).
HuGE Navigator does not only include the database described above, it also
includes some applications in its framework. They allow users to navigate and search
the database in an integrated way. One of them is a search engine for finding
published literature about human genome epidemiology such as genetic association
studies, namely, The HuGE Literature Finder (Yu, Yesupriya et al. 2007). Another
search engine is The HuGE Investigator Browser, developed for finding investigator
networks for a given research interest. Huge Navigator also aids in following new
trends in human genome epidemiology research. HuGE Watch (Yu, Wulf et al. 2008)
has been in the list of those applications for this purpose.
The application set includes a tool called Gene Prospector (Yu, Wulf et al.
2008) for scientists who seek for candidate genes for an interested subject. Also all
published Genome Wide Association Studies in GWAS catalogue (Hindorff,
Sethupathy et al. 2009), curated by the National Human Genome Research Institute,
can be queried in a robust way via GWAS Integrator (Yu, Gwinn et al. 2008). This
bioinformatics tool also provides analytic functionalities for these studies. The data
compilation is based on the GWAS Catalog (Hindorff, Sethupathy et al. 2009),
HapMap (2003; 2004; 2005; Thorisson, Smith et al. 2005; Frazer, Ballinger et al.
2007; Altshuler, Gibbs et al. 2010), SNAP (Johnson, Handsaker et al. 2008).
Interested GWAS study hits after some lookup can be converted to the UCSC
browser (Kent, Sugnet et al. 2002) as query based custom tracks. Integration of SNPs
14
in close proximity and candidate genes from the HUGE Navigator to explore
potential associations between GWAS hits and diseases/traits of interest is also
possible. At the end the HuGE Navigator search results can be downloaded as a text
file.
Most authors use historical or common names for annotating the genetic
variants in the abstracts of their publications. This makes search criteria confusing
for finding the studies relating a reference SNP number to some diseases or
phenotypes. To match the rs numbers to the studies, HuGE Navigator provides a tool
called Variant Name Mapper (Yu, Ned et al. 2009). This tool is a search engine that
utilizes a database, mapping rs numbers to historical or common names of genetic
variants. For validating genetic variations for health outcome predictions by
calculating epidemiologic measures, HuGE Risk Translator also has been developed
(Yu, Gwinn et al. 2008).
HuGE Navigator is an open source project and one can download presented
data and tools from their website. The tool set includes also two online
encyclopedias, Phenopedia and Genopedia (Yu, Clyne et al. 2010). They summarize
the studies for gene-disease and gene phenotype associations respectively.
1.6 ENSEMBL PROJECT
Ensembl (Flicek, Amode et al. 2011) is the name of the project founded and
maintained by collaborative efforts of two important institutions, EMBL-EBI and
Welcome Trust Sanger Institute. Since 1999, before the accomplishment of the draft
of Human genome, the aim of the project has been providing databases for
vertebrates and software system automatically annotating the genomes in many ways
through integration of other resources agreed. Altough the project has been initiated
in 1999 the website has started to serve in July 2000. The assemblies and DNA
sequences used in Ensembl gene builds have been provided by versatile global
projects, each of which is documented in home pages of relevant species in
www.ensembl.org.
Number of genomes handled in Ensembl project has been increasing. The
amount of information provided is extensive (i.e., 56 species supported in Ensembl
15
build 59, completed in August 2010) data on human, mouse, rat and zebrafish are
widely used.
Apart from the core sequence information of those 56 species and their
annotations, Ensembl project also provides variation data, comparative genomics
data, regulation data and Perl API (Stabenau, McVicker et al. 2004) for
programmatic access. Among those, the ones, for which the most up-to-date
developments have been reported, will be mentioned in this thesis.
The data stored in Ensembl is updated several times in year. All the softwares
and data are freely available for download and installation.
1.6.1 Comperative Genomics
Ensembl project enlarges by the addition of new databases, especially the
genome databases for the species genomic sequences of which are getting completed.
Thus enormous computer power is needed to do genomic alignments for every
update of Ensembl gene builds. Ensembl project has also solved this problem by
creating an automatic pipe (Severin, Beal et al. 2010) for genomic alignments to
determine homologues and orthologues genes and gene trees (Vilella, Severin et al.
2009).
1.7 RATIONALE AND AIMS
In the past, tissue specificity of microRNAs has been shown. Recent studies
started to compile profiles and to perform meta-analyses. For example, Bargaje et al,
have processed all datasets to find tissue specific and tissue invariant microRNA
profiles (Bargaje, Hariharan et al. 2010). Furthermore some databases already house
microarray expression data allowing for the presentation of such datasets for a
queried microRNA, such as miRGator (Nam, Kim et al. 2008) and MicroRNA.org
(Betel, Wilson et al. 2008), as mentioned earlier. Other databases exist that compile
existing microRNA species from different organisms and report on their sequence
and target specificity (Griffiths-Jones 2006; Sethupathy, Corda et al. 2006; Megraw,
Sethupathy et al. 2007; Maselli, Di Bernardo et al. 2008; Wang 2008; Taccioli,
Fabbri et al. 2009; Hsu, Lin et al. 2011; Yang, Li et al. 2011). However, there has not
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been any microRNA database that incorporates expression data together with
sequence data and allows multivariate visualization and expression
enrichment/depletion analysis.
In the present study, I aimed to incorporate sequence and expression features
of microRNAs together in a user friendly, modular and easily updatable manner
within and among species. The importance of this aim comes from the fact that most
of the microRNAs have been discovered by detecting conserved 3’UTR regions not
only within species but also between species. This suggests that the presence of a
seed sequence motif in a group of microRNAs may imply a common function since
all of the microRNAs sharing the motif will target the similar mRNAs that bears the
target sequence. This leads to the question of whether microRNAs having a
particular seed sequence have similar expression patterns in terms of tissue or disease
specificity.
Accordingly, the present thesis has focused on creating a tool for expression
pattern analysis of a given set of microRNAs specified by their sequence motifs or
tissue specificity. Furthermore, users might have their own datasets to compare with
existing datasets increasing the need for user data upload facilities. For example, a
study exemplifying this idea shows that AAGTGC motif is a stem cell specific seed
motif. Furthermore, this set of microRNAs has been claimed as cancer
discriminating microRNAs (Laurent, Chen et al. 2008). We can test this by:
A) Gathering and uploading different tissue and cancer microRNA datasets;
B) Selecting the group of microRNAs with the AAGTGC motif;
C) Visualizing the tissue and cancer specific expression profiles using
multivariate techniques;
D) Defining the expression specificity by using an association index and;
E) Comparing expression profiles across different expression studies within
and between species.
mESAdb then aims to provide an online tool by which the aims listed above
(A-E) could be performed using an online tool and in an interactive and user-
specified manner.
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1.8 CONTRIBUTIONS
mESAdb contributes to the scientific community by permitting analysis of
the relationship between expression patterns of microRNAs and their sequences via
multivariate analysis techniques mentioned in the Materials and Methods section.
One of the strengths of mESAdb originates from its use of R language for statistical
calculations and visualization packages; this makes mESAdb modular and
expandible. Others include the ability to select subsets of microRNAs for sequence
and expression analysis via file upload, manual entry or through motif search
options. This feature of mESAdb allows for integration of motif sequence with
expression datasets. Other contributions by mESAdb can be summarized as:
1) Mining of default tissue-specific microRNA expression data sets
across human and mouse and zebrafish;
2) Ability to upload any microRNA expression dataset in a .csv format
and allow for automatic annotation based on miRBase entries;
3) Pair-wise multivariate analysis of expression data sets within and
between taxa using MADE 4.0;
4) Application of phi-coefficient for enrichment analysis of microRNA
expression for a given expression class and a set of microRNAs;
5) Comparison of a dataset with common motif sets in the seed regions
of microRNAs;
6) Association of microRNA subsets with annotation databases, HuGE
Navigator, while other microRNA databases focused KEGG and GO.
Expression pattern analysis and functional annotation for a single microRNA
are also possible by the ‘microRNA Search’ module of mESAdb.
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CHAPTER 2: METHODS
2.1 STATISTICAL METHODS USED IN MESADB
A unique feature of mESAdb is the on-the-fly utilization of various statistical
methods on collected microRNA array data and other gene oriented data integrated
from other sources by using the statistical environment R (R 2010). For multivariate
analysis solutions the MADE4 (Culhane, Thioulouse et al. 2005) packcage from
Bioconductor (Gentleman RC 2004) has been used. For example, ‘co-inertia
analysis’ provided in MADE4 has been used for comparing two array datasets or
comparing any dataset with motif distribution whereas ‘correspondence analysis’ has
been used for representing the match between tissues and microRNAs in two-
dimensional space.
Besides the R packages for specific statistical analyses, generic R functions
e.g., for term enrichment, ‘hyperp’, hyper geometric distribution function (Johnson,
Kotz et al. 1992), have also been used.
A modified version of ϕ-coefficient (Guilford 1941), a basic example of item
set analysis, has been used to assess the significance of expression values of the
selected microRNAs.
2.1.1 PCA-based multivariate data analysis
Principal Components Analysis (PCA) (Pearson 1901; Hotelling 1933; Jollife
2002) is the representation of multivariate data using new set of axes, the number of
which is much smaller than the interrelated variables such that new axis set could
capture as much variation as possible, in the multivariate data. These new set of axes
are called Principal Components (PCs) (Jollife 2002). Those new axes are
uncorrelated and orthogonal to each other. Another property of these axes is that PCs
are ordered according to the variance that they carry i.e., the first one caries the most
of the variance and second one represents the second highest variance and so on
(Jollife 2002).
For the first time Hilsenbeck et al, (1999) introduced the PCA method to
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microarray data analysis. In this study they have found the genes, expression levels
of which have been changed during the tamoxifen resistance acquisition in MCF7
cells (Hilsenbeck, Friedrichs et al. 1999). They have determined three components:
1-) Genes with average expression, 2-) Gene expression levels that differ between the
estrogen stimulated cells and tamoxifen applied cells, 3-) and again gene expressions
that can discriminate tamoxifen resistant and sensitive cells (Hilsenbeck, Friedrichs
et al. 1999).
There are some other studies in which PCA is applied to analyze microarray
data. The main focus of two of the studies was to catch the linear trends in
microarray data in which variables had been accepted as conditions and the genes
had been treated as observations (Raychaudhuri, Stuart et al. 2000; Crescenzi and
Giuliani 2001). However, one of the following studies have applied PCA as
correspondence analysis to microarray data to discover the association between
samples and genes (Fellenberg, Hauser et al. 2001). Finally, the use of PCA arrived
at cross platform microarray data analysis and comparison via co-inertia analysis
(Culhane, Perriere et al. 2003). Culhane et al. (2005) have developed an R package
that could cover those PCA applications mentioned above for all kinds of expression
data (Culhane, Thioulouse et al. 2005).
In mESAdb, I have used the PCA technique indirectly by utilizing
correspondence and co-inertia analysis as provided by MADE4 package. Following
sub sections those applications have been described.
2.1.2 Correspondence Analysis
PCA and Correspondence Analysis (CA) (Fellenberg, Hauser et al. 2001) are
similar that both reduce the dimensions of a space in a data matrix. CA deals with
two variables at the same time whereas the PCA deals with one. Also, via CA, it is
possible to plot both genes, vectors of the condition space, and conditions, vectors of
the gene space, onto the same space with reduced dimensionality. These projections
accomplished by CA method aim to reveal the associations between the two
variables (e.g., microRNAs and tissue types).
In the work of Fellenberg et al. 2001, (Fellenberg, Hauser et al. 2001) the
algorithmic procedure for CA has been defined as follows and is summarized herein:
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Let M be the K by L data matrix with N elements where K represents genes and L
represents conditions in output of a microarray experiment. To formulate the
correspondence analysis, for practical reasons, some concepts have been denoted as
following:
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λ is the diagonal matrix carrying the singular values of the matrix S.
Elements of this diagonal matrix should be ordered from the highest to the lowest
since they are positively correlated with the co-variances captured. The new axes are
the matrices U and V. Hence, the new coordinates of genes and the conditions are:
iikkik rug /λ= and jjkkjk cvf /λ= respectively for k=1,…,L.
2.1.3 Co-inertia Analysis
Co-inertia analysis (Culhane, Perriere et al. 2003) is a mathematical method
for capturing and determining the co-relationships in multivariate datasets. As in the
CA and PCA, for CIA the principle is the same: finding two or three axes that
maximize the variances of the points plotted on them. Again as mentioned in
correspondence analysis the axes and Eigen values are ordered according to amount
of variances that they carry or represent, such that the first axis is the one that carries
the maximum variances of projected points and the second is so among the
remaining axes orthogonal to the previous one and so on. Here some concepts again
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have been denoted to explain the mathematical basis of CIA as explained in Culhane
et al., 2003 (Culhane, Perriere et al. 2003):
From the notations of previous section those are handled;
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Here, B is a K by K matrix but this time it is not correspondence matrix, it is
correlation matrix. Again we can decompose it to its singular values where
.
TVUB λ= Scaling by the c values each of which belongs to one dataset while
determining the coordinates in new space would create two points for each gene one
from each dataset. Hence the vectors seen on the microRNA plots after co-inertia
analyses represent this case. In those plots, while the starting point of an arrow is
belonging to the projection from the first dataset, the end point of it represents the
projected coordinates from the second dataset.
2.1.4 φ-Coefficient
φ-coefficient is a statistical measure introduced by Karl Pearson (Cramér
1946). Its value represents the association between two binary variables,
observations of which are held in a contingency table. Let the binary variables be x
and y, then to contingency table will be:
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Table 2.1.1: A sample contingency table of two binary variables, x and y.
y=1 y=0 total
x=1 n11 n10 n1+
x=0 n01 n00 n0+
total n+1 n+0 n
Then the φ coefficient will be
0101
01100011
++++
−
=Φ
nnnn
nnnn
.
2.1.4.1 φ-coefficient based barplot:
φ-coefficient has been applied to barplots in mESAdb to show the association
between selected microRNAs and each selected tissue (e.g., brain vs 10 other
tissues). Let the expression data for the barplot be a matrix M of m rows and n
columns, where the individual microRNAs are the rows, the classes (tissues) are the
columns and each Mij is the expression level of microRNA i in condition j. Also,
without loss of generality, let the microRNAs in the selected group (group P) be
rows from 1 to k and the rest (group N) be from k+1 to n. For any class j of the n
classes, the φ coefficient of the selected microRNAs can be calculated by ranking the
centroid of these microRNAs. The centroid of the P-group microRNAs from 1 to k in
class j is defined as:
CPj =
1
k
M ij
i=1
k
∑
The centroid of group N is likewise defined as:
CNj =
1
n − k
M ij
i=k+1
n
∑
The rank R of a centroid is the number of rows (microRNAs) in that column
that have an expression higher than that centroid. For example, if in a case, CPj is less
than 25 microRNA expression levels in class j, then RPj will be 25.
Since the φ coefficient is also affected by the absence of expression in other
classes, as well as the presence of expression in the given class, a virtual column ¬j
has been defineed such that it represents all the classes (columns) other than j. The
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values of each row in ¬j are calculated as follows:
M i,¬j =
1
n −1
M ik
k =1
n
∑
 
 
 
 
 
 − M ij
 
 
 
 
 
 
Given these calculations, the φ coefficient is simply:
φPj =
RNjRP¬j − RPjRN¬j
RPjRNjRP¬jRN¬j
The φ coefficient varies between 1.0 and -1.0, positive values showing
positive differential expression (enrichment) for the microRNAs in group P in class j
and negative values showing negative differential expression (depletion). Values of φ
at or around zero denote the independence of group P expression from class j.
The φ coefficient is related to the χ2 statistic given the population. Since here
two classes (j and ¬j), each with m microRNAs (rows) have been concerned, the
population is 2m. Hence, the χ2 statistic becomes:
χPj2 = 2m φPj( )2
This can in turn be used to test significance and calculate a p value using
Pearson’s χ2-test.
2.1.5 K-Means Clustering
It is a widely used clustering algorithm that clusters M points of N
dimensions into desired K clusters, where K<M. So the inputs of the algorithm are
an M by N matrix and a K centers with N dimensions (Hartigan and Wong 1979).
The cluster assignment criteria is to minimize the sum of squares in each clusters
(Hartigan and Wong 1979).
2.2 DATABASE DESIGN
mESAdb enables access and retrieval of microRNAs with specified motifs to
associate and analyze them functionally as well as based on expression profiles
(Figure 2.2.1). An initial version of this work was presented in abstract form in
BioSysBio 2007: Systems Biology, Bioinformatics, Synthetic Biology (Kaya,
Karakulah et al. 2007).
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Figure 2.2.1: Screenshot of the mESAdb main page. The modules, ‘motif-expression’,
‘expression-expression’, ‘motif-function’ and ‘microRNA search’, are shown.
2.2.1 Data collection and storage
Data used in mESAdb are obtained periodically from multiple sources and
processed for integration into the underlying MySQL database using a series of
routines which download, parse and integrate these data from relevant sources
(Ensembl, miRBase, microCosm, HuGE, KEGG and GO) either directly or through
the Biomart integration service (Figure 2.2.1and Figure 2.2.2) (Ashburner, Ball et al.
2000; Kanehisa and Goto 2000; Durinck, Moreau et al. 2005; Griffiths-Jones, Saini
et al. 2008; Yu, Gwinn et al. 2008).
The mentioned integration of different databases has been accomplished by a
python script (Rossum May 1995). To get the mature microRNA names and their
sequences for four species, miRBase (Ambros, Bartel et al. 2003; Griffiths-Jones
2004; Griffiths-Jones, Grocock et al. 2006; Griffiths-Jones, Saini et al. 2008;
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Kozomara and Griffiths-Jones 2011) has been used by the script. First, all mature
names and their sequences are downloaded from this database. Then a unique union
of mature microRNA name list has been constructed. This part of the script ends up
with the MySQL table which is constructed from mature microRNA names and their
sequences for four species. The column names of the table are ‘mirna’ and short
names of considered species, namely, ‘hsa’, ‘mmu’, ‘cel’ and ‘dre’. This table
establishes the core of the mESAdb. It enables selection of mature microRNAs with
their sequence properties when required. Another utility of this table is up-to-date
annotation of the probe sequences in any high-throughput expression dataset to be
used in mESAdb.
26
Figure 2.2.2: Workflow diagram of mESAdb. MESAdb combines data from a variety of
external data sources. For example, microRNA mature sequences and IDs are retrieved from
miRBase and matched with microRNA data sets (e.g. from GEO). microRNA sequences are
processed by the MEME motif finder for conserved motifs. The microRNA targets are fetched
from EBI’s MicroCosm Targets for each species; BioMart is used to get the ENSEMBL Gene
IDs of the targets’ transcript IDs. These ENSEMBL Gene IDs are then linked to HUGE
Navigator Disease IDs, KEGG Pathway IDs and GO IDs. A user-friendly interface has been
developed in PHP for accessing data in the system and allowing versatile analysis via various R
scripts (http://php.net; http://www.r-project.org./;http://www.mysql.com/).
In the current version of mESAdb, mature microRNA names and sequences
were downloaded from miRBase Release 15 (Griffiths-Jones, Grocock et al. 2006).
MicroRNA microarray experiment data sets for human, mouse and zebrafish,
primarily focusing on expression from different tissues and developmental stages
were stored separately as default data sets (Barad, Meiri et al. 2004; Thomson,
Parker et al. 2004; Baskerville and Bartel 2005; Beuvink, Kolb et al. 2007; Ach,
Wang et al. 2008; Navon, Wang et al. 2009; Meiri, Levy et al. 2010) (
Table 2.2.1). Tables containing the normalized expression values were
27
associated with sequence data linked with the corresponding miRBase names for
these microRNAs (Figure 2.2.2). Where available, the probe sequences printed on
microarrays that match exactly with the species-specific reverse complementary
sequences in miRBase were included resulting in increased stringency; thus the
number of microRNAs from each microarray study incorporated into mESAdb might
be smaller than that reported in the original study. Expression data were
logarithmically transformed where necessary, and quantile normalized (Bolstad,
Irizarry et al. 2003).
To link sequence and expression properties with functional information, the
predicted human targets were retrieved from MicroCosm Targets (Figure 2.2.2)
(Griffiths-Jones, Saini et al. 2008). MicroCosm microRNA-target gene matching
files have been used to construct the species specific microRNA-target tables using
the same python script.
These targets were further processed on the R environment (Version 2.11.1)
(R 2010); transcript IDs were matched with Ensembl Gene IDs (Ensembl Relese 59)
using the package biomaRt (Durinck, Moreau et al. 2005). Only a single Ensembl ID
was retrieved for each target gene with multiple transcript entries. Species-specific
microRNAs were paired with target gene IDs associated with ontology terms and
these matched pairs were stored in mESAdb’s underlying DBMS (Figure 2.2.2;
MySQL). KEGG and Gene Ontology terms associated with microRNA targets were
extracted and matched with the corresponding microRNA ID (Ashburner, Ball et al.
2000; Kanehisa and Goto 2000). The disease terms associated with microRNA
targets were obtained from the phenopedia view of HuGE Navigator; these terms
were parsed and matched with microRNA targets and stored in the MySQL table
underlying mESAdb. HuGE and KEGG databases use Entrez gene IDs. To convert
those Entrez gene IDs to target Ensembl IDs, the script uses the BioMart database.
The database also has been used for target gene-gene ontology term matching in the
species specific MySQL tables. Target and associated terms are updated as the script
is called either by hand or periodically (Figure 2.2.2).
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Table 2.2.1: Default data sets provided in mESAdb
Tissue Abreviations. Fallopian tube (F), Uterus (U), Lymph node (Ly), Placenta (Pl), Breast(Br), Pancreas (Pa), Liver (Li), Brain (B), Thymus (Th), Heart (H), Lungs (Lu),
Spleen (Sp), Testicle (Te), Ovary (O), Kidney (K), Skeletal muscle (SM), Small intestine (SI), Colon (Co), Prostate (Pr), Bladder (Bl), Cervix (Ce), Adrenal gland (A),
Stomach (St), Bone Marrow (BM), Frontal Cortex (FC), Eye (Ey), Gill (Gi), Fin (Fi), Skin (Sk), Gut (G), HeLa Cells (HeLa), HeLa S3 (HL3S), Endometrium (En).
Name Species GSE NO. Platform Pubmed ID Tissues
Meiri et al., 2010 Homo sapiens GSE20414 GPL10067 20483914 Ly, K, En, Lu, Bl, B, H, Li
Navon et al., 2005 Homo sapiens GSE14985 GPL8227 19946373 Br, Pr, Ly, O, Co ,Li, Te, Lu
Ach et al., 2008 Homo sapiens GSE11806 GPL6955 16783629 Pl, B, Br , H,Th, Li, O, SM,Te
Barad et al., 2004 Homo sapiens - MOE-ER ar ray 15574827 HeLa, B, Li, Th, Te, Pl
Baskerville & Bartel 2005 Homo sapiens - MWG biotech 15701730 BM, B, H, K, Li, Lu, Pa, Pr, SM, Sp, Th, FC, Ly, Co, HelaS3, Ce, Bl, Te, A, U, Br, F, SI, Pl, O
Wienholds et al., 2005 Danio rerio GSE2628 GPL2023 15919954 B, Ey, SM, H, Gi, Fi, Sk, G, Li, Te, O
Thomson et al., 2004 Mus musculus GSE1635 GPL1391 15782152 Li, K, Lu, O, H, B, Th, ES, EBD3, EBD28, E7, E11, E15, E17
Beuvink et al., 2006 Mus musculus - Custom 17355992 HeLa, B, Li, Lu, SI, SM, H, K, Sp
2.2.2 User-specified expression data set management
mESAdb incorporates a tool for the upload of user-specified expression data
sets provided as comma separated files (Figure 2.2.3). The user is free to add, view
and remove expression data sets having expression data for arbitrary numbers of
microRNAs against arbitrary number of expression classes (e.g. tissues,
developmental stages, disease states). The format for the input file is straightforward:
a comma delimited file with the first row giving the names of the classes, the
subsequent lines of the file each beginning with the name of the microRNA (e.g. the
miRBase ID) and, optionally, the probe sequence, followed by the measured
expression for each of the classes given in the header line. The file uploaded is
preprocessed line-by-line; for each, if the reverse complement of the probe sequence
given for that line contains the mature sequence for the corresponding microRNA as
given in the latest miRBase, the line is verified. For lines that cannot be thus verified,
the system searches for a match in the miRBase sequences for the relevant species. If
found, the microRNA is renamed to its miRBase standard name, if not, the line is
discarded. Subsequently, the lines for duplicate microRNAs are averaged. The
upload module generates a downlodable text file listing the actions performed while
parsing and processing the csv file. mESAdb uses nomenclature by miRBase for
cross taxa comparisons performed in ‘expression–expression’ module where
microRNAs with the same name from two different species are matched. Most
microRNAs carrying the same name exhibit high sequence similarity across species
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while ~5% are relatively divergent.
Figure 2.2.3: Screenshot of the data upload module. User can select from species and
microarray normalization options and then browse to upload a data set.
The data upload utility also warns users in such cases. The module also
provides utilities to log-transform, center and scale or quantile normalize the
expression data upon verification by miRBase (Figure 2.2.3). A user-uploaded
dataset is tied to the specific user account that creates it and may have been retrieved
from another source or may be the product of the users’ own research. The designed
system protects privacy of proprietary data by keeping uploaded sets visible only to
the account that owns it and no data is retained once a user removes a data set.
An exemplary data set was provided in the current version of the mESAdb
(i.e. GSE2564NORMAL_seq.csv; mESAdb supporting material;
http://konulab.fen.bilkent.edu.tr/mirna/supplementary_files.php) (Lu, Getz et al.
2005). Accordingly, GSE2564 expression series matrix was downloaded from GEO
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(Barrett, Troup et al. 2009). This data set includes normal tissues from stomach
(n=5), colon (n=5), pancreas (n=1), liver (n=3), kidney (n=3), bladder (n=2), prostate
(n=8), uterus (n=9), lung (n=4), breast (n=3) and brain (n=2), together with cancer
samples for different tissues. For the example used herein, only the expression data
on the normal tissues were obtained; linked with microRNA annotations and probe
sequences in the GPL1986 description file; and a comma separated file was formed
for upload. An account of processing of the microRNAs in the .csv file was
generated by mESAdb. The data set, called GSE2564_normal, could be uploaded
using the ‘Manage Datasets’ facility of mESAdb (Figure 2.2.3) and compared with
the existing data sets listed in
Table 2.2.1.
2.3 INTEGRATION OF R PACKAGES
mESAdb uses a hybrid of PHP and R as a computational environment. The
basic operations and the web interface elements are coded in PHP whereas more
significant statistical analyses such as co-inertia, correspondence, the φ coefficient
and p-value calculation and hyper geometric distribution tests for HuGE, KEGG and
GO terms are performed in R (Figure 2.2.2). The web interface has been made as
responsive and user-friendly as possible with the addition of dynamic elements
created with JavaScript and the JQuery UI (http://jqueryui.com/) library.
The communication between the PHP and R environments is performed using
the common underlying MySQL database and Unix based operating system pipes.
Briefly, a PHP script creates a child R process to which command line arguments are
passed onto. The R process uses this information to retrieve the relevant information
from the MySQL database and subsequently prepares the output (e.g. graphics; the
bar plot, correspondence plots) which it passes onto the calling PHP script to display
on the page. If the output is mostly textual (e.g. tabular data), it is passed on the
output stream of the R program via PHP serialization package. If it is a larger result
like an image, the R program saves it under a predetermined, random and client
specific file name in a temporary location, which the PHP script retrieves from once
the child R process is finished. This two-way communication between the PHP code
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and its R child processes has been implemented as a simple but effective API, which
allows new R scripts to be easily integrated into the mESAdb tool as needed.
2.4 MESADB MODULES
2.4.1 Motif Expression
mESAdb has a motif selection tool with a pulldown menu in which users
might select from different options to group retrieved microRNAs with a given
motif, i.e. dinucleotide motifs or motifs up to 6 nucleotide long using the IUPAC
code (Panico, Powell et al. 1993). It is also possible to upload user-specified
microRNA lists. ‘Motif-expression’ module integrates the motif selection tool with
default microarray data sets found in mESAdb as well as those uploaded by the user
(Figure 2.2.1, Figure 2.2.3 and
Table 2.2.1).
Accordingly, mESAdb provides a platform for visualization of microRNA
expression in humans, mouse and zebrafish. Once a microRNA list is selected,
expression of this set of microRNAs can be investigated using three different
analysis options: ‘expression analysis’, ‘correspondence analysis’ and ‘co-intertia
analysis’ (Culhane, Thioulouse et al. 2005).
The ‘expression analysis’ option enables the user to compare, using bar plots,
the amount of mean expression of the selected microRNAs with those of the
remaining microRNAs across the studied expression classes, i.e. tissues or
developmental stages. Expression data (
Table 2.2.1) for the selected microRNAs and those for the unselected
microRNAs are extracted from the quantile normalized log transformed expression
tables that have been generated by the mESAdb data upload facility. The class (e.g.
tissue) specific mean values for the selected and unselected microRNAs then are
plotted separately for each column of the data set (e.g. each tissue) using a bar plot.
Bars are color coded by the value of the ϕ-coefficient to assess the association of the
selected microRNAs with the tissue in consideration (also called the Yule-ϕ)
(Guilford 1941). A dynamic hover feature has been implemented for user to see
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exact information about each column by hovering the mouse pointer over it in the
barplot. Expression data sets are accessible in the html format, and the χ2 and P-
values for the φ-coefficient also are generated. Help boxes are made available for
data plots and analysis tools.
mESAdb performs multivariate analysis of expression using the R package
MADE4 customized for visualization and analysis in mESAdb (Culhane, Thioulouse
et al. 2005). ‘Correspondence analysis’ of the selected set of microRNAs produce
three graphical outputs, allowing for visualization of the expression patterns across
classes (e.g. tissues), or microRNAs, or both the classes and microRNAs. ‘Co-inertia
analysis’ (Culhane, Thioulouse et al. 2005) of the selected set of microRNAs helps
visualize the similarities between microRNA expression and occurrence of common
6-mer MEME (Bailey and Elkan 1994) motifs found among the microRNA
sequences housed in mESAdb. Users can link from a motif to back to the ‘expression
analysis’ module explained above to visualize the expression data as bar plots per
expression class (e.g. tissue), of the group of microRNAs used in the co-inertia plot
containing the specified motif . MEME motif outputs we generated for the human,
mouse and zebrafish microRNAs can be accessed from the supporting material
(http://konulab.fen.bilkent.edu.tr/mirna/supplementaryfiles.php) found at the
mESAdb.
2.4.2 Expression-expression
This module provides a tool for meta-analysis of microRNA expression data
sets. Selected sets of microRNAs can be investigated with regard to the datasets
listed in
Table 2.2.1 in a pairwise fashion; other user-defined data sets can be
uploaded and analyzed as well (Figure 2.2.1). ‘Expression–expression module’
outputs co-inertia graphics for (i) classes (e.g. tissues) and (ii) microRNAs, and also
a heatmap of both data sets using customized MADE4 (Culhane, Thioulouse et al.
2005) and heatplus
(http://bioconductor.org/packages/2.6/bioc/vignettes/Heatplus/inst/doc/Heatplus.pdf)
packages in R (www.bioconductor.org). The output has been customized for better
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visualization; and the degree of association, indicated by the RV coefficient (Robert
and Escoufier 1976; Culhane, Thioulouse et al. 2005) between two different
microarray data sets also is provided. A high RV score suggests better correlation
among data sets. For the microRNA oriented co-inertia graph, several utilities are
provided in order to facilitate the visualization of potentially high numbers of data
points. It is possible to visualize the microRNA data points with or without labels on
the co-inertia graph. The co-inertia tool also provides an automatic clustering of the
microRNAs based on the similarity of their expressions in both data sets using k-
means clustering (Hartigan and Wong 1979); the default clustering displayed is the
clustering with the maximum silhouette coefficient (Lovmar, Ahlford et al. 2005).
Since k-means clustering is not deterministic, for each k-value the module performs
20 runs of the algorithm and the best clustering for each k is selected using highest
silhouette. The clustering with the overall best silhouette is displayed by default. The
user can manually set a cluster number between 2 and 10 clusters (i.e. 2 ≤ k ≤ 10) if
desired. These clusters can further be investigated to visualize the expression profiles
for the given datasets using expression bar plots of in-cluster and out-of-cluster
microRNAs, by clicking on the cluster centroids.
2.4.3 Motif-function
This function may be useful for functional analysis of, for example, a set of
differentially expressed microRNAs (Figure 2.2.1 and Figure 2.2.2). In the present
study, information from HuGE Navigator, in addition to GO and KEGG databases
can be associated with the selected microRNAs (Ashburner, Ball et al. 2000;
Kanehisa and Goto 2000; Yu, Gwinn et al. 2008). For any selected subset of
microRNAs, mESAdb then can be used to retrieve the mappings of the selected
functional terms, with the targets of these microRNAs and subsequently to calculate
a probability value based on the hypergeometric distribution (Kachitvichyanukul and
Schmeiser 1985). Functional and expression correlates of a single microRNA can be
assessed using this module to enable a quick search involving multiple modules of
mESAdb (Figure 2.2.1). Terms from GO, HuGE, KEGG and target genes associated
with the given microRNA can be extracted; and the observed and expected counts as
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well as hypergeometric P-values can be downloaded. Expression profile of the
selected microRNA also can be visualized using the aforementioned bar plots and
downloaded as .txt files.
2.4.4 microRNA search module
This module is a partial combination of the other three modules for a single
microRNA of interest. The main objective of this module is to associate a single
microRNA with target information as well as with expression profiles. One can also
look up relevant disease relations through HuGE phenopedia and genopedia, GO
terms, KEGG pathways for that microRNA (Figure 2.4.1).
Figure 2.4.1: Snapshot of microRNA search module. In this module, one can apply every
analysis function, that are applicable in mESAdb for a single microRNA.
2.4.5 Data processing for default expression datasets
2.4.5.1 Ach et al., (2008) (Ach, Wang et al. 2008):
This dataset has been downloaded from NCBI’s GEO (Edgar, Domrachev et
al. 2002; Barrett, Troup et al. 2011) web site through files in SOFT format (Simple
Omnibus Format in Text) linked with the GSE11806 accession number and read
locally by Bioconductor’s GEOquery (Sean and Meltzer 2007) package. The data
matrix of hybridization intensities and probeset information of the array have been
fetched from it. The values in the data matrix have been log transformed first and
then the arithmetic means of the replicate columns have been taken. The column
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names have been replaced by agreed upon tissue abbreviation codes. Then the data
was turned into a data frame satisfying our data upload format and written to a .csv
file. Since it has no sequence information the column specified as “sequence” field in
upload data format has been left empty. After all, the data was uploaded to the
database as a human dataset after checking the quantile normalization (Bolstad,
Irizarry et al. 2003) option.
2.4.5.2 Barad et al., (2004) (Barad, Meiri et al. 2004):
This dataset comes with an annotated and non log transformed background
corrected signal intensity matrix; the annotation table includes sense probe sequence
information, which was first converted to antisense, and then matched with
microRNA names and assigned to each row of the expression matrix before
uploading. When using upload module, data was log transformed and quantile
normalized (Bolstad, Irizarry et al. 2003).
2.4.5.3 Baskerville & Bartel (2005) (Baskerville and Bartel 2005):
This dataset comes as a signal intensity matrix in which the values below the
background intensity have been replaced with the background value. The sequence
annotations of miRNAs have been also provided. The same procedure as in Barad
data was followed.
2.4.5.4 Beuvink et al., (2007) (Beuvink, Kolb et al. 2007):
This dataset normally includes raw signal intensity matrix neither normalized
nor background corrected. Sequence annotation was provided and used to update
microRNA names while being uploaded. The data were log transformed and quantile
normalized.
2.4.5.5 Meiri et al., (2010) (Meiri, Levy et al. 2010):
This dataset was downloaded from the NCBI’s GEO (GSE20414). Only the
array samples from the normal tissues were selected. The dataset given in the SOFT
formatted file type had already been normalized through best fit to a reference array
and log transformed at base 2. The GPL contains sequence information, thus during
the preparation for upload this has been considered. Data was quantile normalized
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(Bolstad, Irizarry et al. 2003) before upload.
2.4.5.6 Navon et al., (2009) (Navon, Wang et al. 2009):
This dataset available in NCBI’s GEO (Edgar, Domrachev et al. 2002;
Barrett, Troup et al. 2011) (GSE14985) is composed of array samples derived from
normal and tumor tissues from 14 different patients. The data had been pre-processed
by replacing values smaller than the background with the background value. By
using R and GEOquery package (Sean and Meltzer 2007), this dataset has been
processed further by log transforming the dataset before selecting normal tissue
samples only and taking the mean of samples from the same tissues. Data was
quantile normalized (Bolstad, Irizarry et al. 2003) before upload.
2.4.5.7 Thomson et al., (2004) (Thomson, Parker et al. 2004):
The dataset includes array samples derived from either adult mice or mice
embryos. Embryonic cell types were separated from the ones of adult origin. The
dataset comes as log transformed, background corrected and median centered. Only
additions to these preprocessing events were that replicated samples were averaged,
and sequence information was added to the data frame. Before upload, the data was
also quantile normalized (Bolstad, Irizarry et al. 2003).
2.4.5.8 Wienholds et al., (2005) (Wienholds, Kloosterman et al. 2005):
This zebrafish dataset was found normalized and mean centered in NCBI’s
GEO (GSE2628) but not log transformed. SOFT formatted files were downloaded,
the expression matrix was log transformed after adding a fixed value to the whole
data matrix making the minimum value in the matrix, 1. Next, the sequence
information from platform data has been integrated to the matrix and data was
quantile normalized before upload.
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CHAPTER 3:RESULTS
mESAdb is a highly interactive and flexible database with an ability to
analyze and visualize selected expression profiles for a given subset of microRNAs
in a multivariate manner using correspondence and co-inertia analyses. One can also
study a single microRNA of interest using bar plots associated with a gene
expression enrichment index, based on the ϕ-coefficient. This index provides a
significance value for the relative enrichment of a microRNA(s) in a particular class
with respect to others. Furthermore, the user can obtain information about the
functional enrichment of a microRNA or a group of microRNAs using different
databases, including GO, KEGG and HuGE Navigator.
3.1 ADDING NEW DATASETS TO MESADB
The default expression data sets currently focus on tissue- and stage-
specificity; however, users can add any microarray data containing other types of
expression classes, e.g. cancer versus normal, treatment versus control (Figure 3.1.2)
(please see Methods section 3.2.2 for another example). This allows for great
flexibility in analyzing one’s own research data.
For example, to demonstrate the data upload utility, the dataset with GEO
accession number GSE10694 (Li, Xie et al. 2008) has been used. The dataset is
already normalized with local background subtraction and quantile normalization.
This dataset, however, has no sequence information in its platform data, GPL6542.
The arrays have been prepared from liver cancer tissues of 78 different patients with
hepatocellular carcinoma, corresponding neighboring non-cancerous tissues of the
same cases and 10 normal liver tissues.
The typical csv file format, where each entry is comma separated and each
line has the same number of entries, was prepared for this dataset to upload it to
mESAdb. First line of the file is header line. The first two columns, “mirna” and
“sequence”, are fixed and represent the mature microRNA name and probe sequence
respectively. The remaining columns represent the arrays containing expression
values. They are re-named such that hcc sample taken from patient number x has
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been named as px_hcc, and normal liver sample taken from the same patient has
been named as pxn where n (tissue from non-cancer individuals) is between 1 and
10. Other lines contain the corresponding values where sequence field is empty since
there is no information coming from the platform data. The sample file prepared can
be downloaded from: http://konulab.fen.bilkent.edu.tr/mirna/hcc.csv. After the
upload, a snapshot of the dataset view is given below (Figure 3.1.1).
Figure 3.1.1: GSE10964 has been added to the database with the name ‘hcc’.
To demonstrate the utility of this dataset in mESAdb, a microRNA seed
sequence motif associated with embryonic stem cell enrichment, i.e., AAGTGC, was
searched within this ‘hcc’ Human dataset using the motif-expression motif (Laurent,
Chen et al. 2008). Correspondence analysis visualization was performed showing
that the microRNAs with the given motif (i.e., miR-106a, miR-106b, miR-20a, miR-
20b, miR-93, miR-520f, and miR-520b; Table 3.1.1) successfully separated the tumor
samples from the adjacent normal and normal samples (Figure 3.1.2). It is apparent
from the correspondence analysis which microRNAs separate the hcc samples from
the normal and vice versa. In fact, the expression of the miR-520f and miR-520b
diverges from the rest and they are relatively more expressed in normal tissues where
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the rest of the microRNAs are overexpressed in hcc samples (Figure 3.1.3). The
findings suggest that stem cell signature might be an important factor in diagnosis of
the hcc.
Table 3.1.1: The list of microRNAs that contain the AAGTGC motif particularly specific to
stem cell populations (Laurent, Chen et al. 2008).
microRNA Sequence
miR-106a AAAAGTGCTTACAGTGCAGGTAG
miR-106b TAAAGTGCTGACAGTGCAGAT
miR-20a TAAAGTGCTTATAGTGCAGGTAG
miR-20b CAAAGTGCTCATAGTGCAGGTAG
miR-520b AAAGTGCTTCCTTTTAGAGGG
miR-520f AAGTGCTTCCTTTTAGAGGGTT
miR-93 CAAAGTGCTGTTCGTGCAGGTAG
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Figure 3.1.2: Plot of samples after the correspondence analysis of the dataset GSE10964 with
microRNAs having ‘AAGTGC’ seed motif.
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Figure 3.1.3: Plot of the microRNAs having ‘AAGTGC’ seed motif after the correspondence
analysis of the dataset GSE10964.
3.2 COMPARISON OF DATASETS ACROSS TAXA
FOR A GIVEN SET OF MICRORNAS
As an example, it has been demonstrated that the user can compare two data
sets with respect to a list of microRNA clusters that are common to both mice and
humans. Using the ‘expression–expression’ module of mESAdb, a human (Meiri,
Levy et al. 2010) and a mouse (Thomson, Parker et al. 2004) data set have been
chosen (
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Table 2.2.1) and then a microRNA list has been uploaded (Table 3.2.1).The
list includes let-7a-i, miR-130a-b, miR-15a-b, miR-181a-b, miR-200a-b, miR-23a-b,
miR-26a-b, miR-29a-c, miR-30a-d and miR-99a-b clusters). Then the coinertia
analysis was performed using only the tissues common to both data sets, namely,
brain (B), liver (Li), lung (Lu), kidney (K) and heart (H) (Figure 3.2.1). Using
coinertia analysis, mESAdb allows for comparison and visualization of two
expression data sets by plotting them side by side in terms of the expression of
selected microRNAs for the given tissues.
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Table 3.2.1: Mature sequences of microRNAs that are used for co-ineria analysis between Meiri
et al., 2010 and Thomson et al., 2004.
miRBase ID Marture sequence in Homo sapiens Marture sequence in Mus musculus
let-7a TGAGGTAGTAGGTTGTATAGTT TGAGGTAGTAGGTTGTATAGTT
let-7b TGAGGTAGTAGGTTGTGTGGTT TGAGGTAGTAGGTTGTGTGGTT
let-7c TGAGGTAGTAGGTTGTATGGTT TGAGGTAGTAGGTTGTATGGTT
let-7d AGAGGTAGTAGGTTGCATAGTT AGAGGTAGTAGGTTGCATAGTT
let-7e TGAGGTAGGAGGTTGTATAGTT TGAGGTAGGAGGTTGTATAGTT
let-7f TGAGGTAGTAGATTGTATAGTT TGAGGTAGTAGATTGTATAGTT
let-7g TGAGGTAGTAGTTTGTACAGTT TGAGGTAGTAGTTTGTACAGTT
let-7i TGAGGTAGTAGTTTGTGCTGTT TGAGGTAGTAGTTTGTGCTGTT
miR-130a CAGTGCAATGTTAAAAGGGCAT CAGTGCAATGTTAAAAGGGCAT
miR-130b CAGTGCAATGATGAAAGGGCAT CAGTGCAATGATGAAAGGGCAT
miR-15a TAGCAGCACATAATGGTTTGTG TAGCAGCACATAATGGTTTGTG
miR-15b TAGCAGCACATCATGGTTTACA TAGCAGCACATCATGGTTTACA
miR-181a AACATTCAACGCTGTCGGTGAGT AACATTCAACGCTGTCGGTGAGT
miR-181b AACATTCATTGCTGTCGGTGGGT AACATTCATTGCTGTCGGTGGGT
miR-200a TAACACTGTCTGGTAACGATGT TAACACTGTCTGGTAACGATGT
miR-200b TAATACTGCCTGGTAATGATGA TAATACTGCCTGGTAATGATGA
miR-23a ATCACATTGCCAGGGATTTCC ATCACATTGCCAGGGATTTCC
miR-23b ATCACATTGCCAGGGATTACC ATCACATTGCCAGGGATTACC
miR-26a TTCAAGTAATCCAGGATAGGCT TTCAAGTAATCCAGGATAGGCT
miR-26b TTCAAGTAATTCAGGATAGGT TTCAAGTAATTCAGGATAGGT
miR-29a TAGCACCATCTGAAATCGGTTA TAGCACCATCTGAAATCGGTTA
miR-29b TAGCACCATTTGAAATCAGTGTT TAGCACCATTTGAAATCAGTGTT
miR-29c TAGCACCATTTGAAATCGGTTA TAGCACCATTTGAAATCGGTTA
miR-30a TGTAAACATCCTCGACTGGAAG TGTAAACATCCTCGACTGGAAG
miR-30b TGTAAACATCCTACACTCAGCT TGTAAACATCCTACACTCAGCT
miR-30c TGTAAACATCCTACACTCTCAGC TGTAAACATCCTACACTCTCAGC
miR-30d TGTAAACATCCCCGACTGGAAG TGTAAACATCCCCGACTGGAAG
miR-99a AACCCGTAGATCCGATCTTGTG AACCCGTAGATCCGATCTTGTG
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Figure 3.2.1: Coinertia plot of Meiri and Thomson expression data sets for a set of microRNA
clusters with sequence similarity. Similarity of microRNA expression patterns between mice and
humans are shown for brain (B), heart (H), kidney (K), liver (Li), and lung (Lu).
Accordingly, it has been found that microRNAs in the uploaded list were
expressed similarly in human and mouse data sets because the location of the
projected tissues closely corresponded between the two plots (Figure 3.2.1).
mESAdb also enables visualization of the expression of selected microRNAs from
both data sets by simultaneously overlaying them on a two-dimensional plot. In this
microRNA-oriented view, similarly expressed microRNAs are found closer in space.
45
Figure 3.2.2: Distribution of microRNAs after dimension reduction by co-inertia analysis.
microRNAs related in expression clustered together.
The figure (Figure 3.2.2) shows the analysis of the uploaded microRNA list
via co-inertia between two dataset of different species. The length of an arrow
coupled to a microRNA correlates with the amount of expression divergence for a
particular microRNA between the two data sets, i.e. human versus mouse. The
analysis result shown in Figure 3.2.2 indicated that several microRNAs formed
clusters based on their expression, in particular, miR-181a and miR-181b, and miR-
200a and miR-200b (Figure 3.2.2). Indeed, miR-181a and miR-181b, similar in
sequence and diverging only with 3 nucleotides, exhibit a common sequence motif
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(i.e. AACATTCA) in their first 8th nucleotides microRNAs having ‘AAGTGC’ seed
motif. Similarly, miR-200a and miR-200b are similar in their sequences containing a
common motif (i.e. TAA[C][T]ACTG) in their first 8 nucleotides (Table 3.2.1).
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Table 3.2.2: Locations of microRNAs in human genome that are used for co-ineria analysis
between Meiri et al., 2010 and Thomson et al., 2004.
Chromosome Start End Strand ENSEMBL ID miRBase ID
9 96938239 96938318 + MI0000060 hsa-let-7a-1
11 122017230 122017301 - MI0000061 hsa-let-7a-2
22 46508629 46508702 + MI0000062 hsa-let-7a-3
22 46509566 46509648 + MI0000063 hsa-let-7b
21 17912148 17912231 + MI0000064 hsa-let-7c
9 96941116 96941202 + MI0000065 hsa-let-7d
19 52196039 52196117 + MI0000066 hsa-let-7e
9 96938629 96938715 + MI0000067 hsa-let-7f-1
X 53584153 53584235 - MI0000068 hsa-let-7f-2
3 52302294 52302377 - MI0000433 hsa-let-7g
12 62997466 62997549 + MI0000434 hsa-let-7i
11 57408671 57408759 + MI0000448 hsa-miR-130a
22 22007593 22007674 + MI0000748 hsa-miR-130b
13 50623255 50623337 - MI0000069 hsa-miR-15a
3 160122376 160122473 + MI0000438 hsa-miR-15b
1 198828173 198828282 - MI0000289 hsa-miR-181a-1
9 127454721 127454830 + MI0000269 hsa-miR-181a-2
1 198828002 198828111 - MI0000270 hsa-miR-181b-1
9 127455989 127456077 + MI0000683 hsa-miR-181b-2
1 1103243 1103332 + MI0000737 hsa-miR-200a
1 1102484 1102578 + MI0000342 hsa-miR-200b
19 13947401 13947473 - MI0000079 hsa-miR-23a
9 97847490 97847586 + MI0000439 hsa-miR-23b
3 38010895 38010971 + MI0000083 hsa-miR-26a-1
12 58218392 58218475 - MI0000750 hsa-miR-26a-2
2 219267369 219267445 + MI0000084 hsa-miR-26b
7 130561506 130561569 - MI0000087 hsa-miR-29a
7 130562218 130562298 - MI0000105 hsa-miR-29b-1
1 207975788 207975868 - MI0000107 hsa-miR-29b-2
1 207975197 207975284 - MI0000735 hsa-miR-29c
6 72113254 72113324 - MI0000088 hsa-miR-30a
8 135812763 135812850 - MI0000441 hsa-miR-30b
1 41222956 41223044 + MI0000736 hsa-miR-30c-1
6 72086663 72086734 - MI0000254 hsa-miR-30c-2
8 135817119 135817188 - MI0000255 hsa-miR-30d
21 17911409 17911489 + MI0000101 hsa-miR-99a
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Table 3.2.3: Locations of microRNAs in mouse genome that are used for co-ineria analysis
between Meiri et al., 2010 and Thomson et al., 2004.
Chromosome Start End Strand ENSEMBL ID miRBase ID
13 48633548 48633641 - MI0000556 mmu-let-7a-1
9 41344799 41344894 + MI0000557 mmu-let-7a-2
15 85537749 85537833 + MI0000558 mmu-let-7b
16 77599902 77599995 + MI0000559 mmu-let-7c-1
15 85537033 85537127 + MI0000560 mmu-let-7c-2
13 48631381 48631483 - MI0000405 mmu-let-7d
17 17967316 17967408 + MI0000561 mmu-let-7e
13 48633198 48633286 - MI0000562 mmu-let-7f-1
X 148346889 148346971 + MI0000563 mmu-let-7f-2
9 106081171 106081258 + MI0000137 mmu-let-7g
10 122422696 122422780 - MI0000138 mmu-let-7i
14 62250864 62250947 - MI0000564 mmu-mir-15a
3 68813694 68813757 + MI0000140 mmu-mir-15b
8 86732417 86732491 + MI0000571 mmu-mir-23a
13 63401792 63401865 + MI0000141 mmu-mir-23b
9 118940914 118941003 + MI0000573 mmu-mir-26a-1
10 126432586 126432669 + MI0000706 mmu-mir-26a-2
1 74440884 74440968 + MI0000575 mmu-mir-26b
6 31012660 31012747 - MI0000576 mmu-mir-29a
6 31013023 31013093 - MI0000143 mmu-mir-29b-1
1 196863234 196863314 + MI0000712 mmu-mir-29b-2
1 196863741 196863828 + MI0000577 mmu-mir-29c
1 23279108 23279178 + MI0000144 mmu-mir-30a
15 68168977 68169072 - MI0000145 mmu-mir-30b
4 120442139 120442227 - MI0000547 mmu-mir-30c-1
1 23298540 23298623 + MI0000548 mmu-mir-30c-2
15 68172770 68172851 - MI0000549 mmu-mir-30d
16 77599181 77599245 + MI0000146 mmu-mir-99a
2 84581272 84581335 - MI0000156 mmu-mir-130a
16 17124154 17124235 - MI0000408 mmu-mir-130b
1 139863032 139863118 + MI0000697 mmu-mir-181a-1
2 38708255 38708330 + MI0000223 mmu-mir-181a-2
1 139863216 139863295 + MI0000723 mmu-mir-181b-1
2 38709350 38709438 + MI0000823 mmu-mir-181b-2
4 155429005 155429094 - MI0000554 mmu-mir-200a
4 155429790 155429859 - MI0000243 mmu-mir-200b
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Figure 3.2.3: Similarity of expression of microRNA expression from Meiri and Thomson.
Expression bar plot of (a) miR-181a and miR-181b cluster (b) miR-200a and miR-200b for five
different tissues [i.e. brain (B), heart (H), kidney (K), liver (Li), and lung (Lu), respectively.].
For each tissue, the bar on the left indicates the mean expression of the members of the cluster
and the right hand bar indicates the mean expression of the remainder of the data set.
Using the ‘expression analysis’ module, miR-181a and miR-181b were found
to be expressed primarily in the brain and lung (Figure 3.2.3-a) whereas the miR-
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200a-b cluster was clearly expressed mostly in the kidney and lung both in mice and
humans (Figure 3.2.3-b). These findings suggested that expression patterns of miR-
181a-b and miR-200a-b were highly conserved between human and mice.
3.3 SEARCHING FOR A DISEASE ASSOCIATION
MICRORNAS USING HUGE NAVIGATOR
This feature is only available for human microRNAs since the HuGE
database deals with human epidemiological studies. Searching for a disease
association for microRNA(s) is possible in two ways. One can either use ‘motif &
function’ module or ‘microRNA search’ module.
In the first option, one can upload a text file, can enter a motif to select a list
of microRNAs that bears it or can select a dinucleotide as directed by the selection
list menu ‘select miRNA upon:’.
Figure 3.3.1: Motif and function module. You can associate GO terms, HUGE terms and KEGG
pathways for a set of selected microRNA by a criteria that you set here.
After choosing the selection criteria the user is directed to a page where one
can analyze the selected microRNAs for either of the following: 1) GO, 2) HuGE and
3) KEGG terms. An example is provided here while focusing on liver specific
microRNAs (Chen 2009). In this editorial, a table showing the list of microRNAs
proven to be expressed in liver according to various studies together with their
expression levels has been adopted from Girard et al (Girard, Jacquemin et al. 2008;
Chen 2009). From this table, the top thirteen microRNAs have been selected, and a
file containing those has been created as a liver-specific microRNA file example.
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Figure 3.3.2: After the upload of liver related microRNAs, the page to which the client is
directed. Here one can associate the microRNAs to HUGE, KEGG and GO terms. FASTA
formats of uploaded microRNAs could also be seen.
As mentioned above, mESAdb allows for upload of a text file containing a
list of microRNAs. In this case, the file containing a list of liver specific microRNAs
obtained from Chen et al, 2009 (Chen 2009), and was uploaded from which one
could associate these microRNAs with a HUGE term together with a probability of
this association being due to change. The result has been shown in the figure below
(Figure 3.3.3). The findings were as expected in that liver specific microRNAs were
found to be associated with liver specific diseases such as Hepatitis B and C.
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Figure 3.3.3: The HUGE terms associated with the uploaded microRNAs primarily expressed in
liver.
One of the ways of associating a microRNA with a disease is investigating
the relationship between its target and the disease. In mESAdb it has been applied.
However, in 2008, Lu et al, have built a database called human microRNA-
associated disease database (HMDD http://202.38.126.151/hmdd/mirna/md/) (Lu,
Zhang et al. 2008). This database has been built by inferring microRNA-disease
association by literature scanning (Lu, Zhang et al. 2008).
A comparison of two database results has been shown here. First, from the
HMDD, hypertension disease was selected (Figure 3.3.3).
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Figure 3.3.4: A snapshot of HMDD. From the left panel “hypertension” was selected and on the
right frame related microRNAs appeared.
microRNAs related to this disease were put into a file and uploaded to the mESAdb
through ‘motif & expression’ module and all 6 microRNAs were found on mESAdb
(Figure 3.3.5). Obviously one should expect a difference between two databases,
since the association methods are different i.e., HMDD uses direct relation mined
from published texts whereas mESAdb uses target gene-disease association via
HuGE Navigator.
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Figure 3.3.5: microRNAs associated to hypertension according to the HMDD were uploaded to
mESAdb.
The association results from mESAdb have been shown in Figure 3.3.6. The
top term is not “hypertension”, however it is a relevant term, namely,
“Cardiovascular Diseases” which includes “hypertension”.
56
Figure 3.3.6: mESAdb association of the selected microRAs to HUGE terms.
3.4 SEARCHING FOR KEGG ASSOCIATED
WITH MICRORNAS
The same set of miRNAs has also been used for finding significantly relevant
KEGG terms. Results are shown in Figure 3.4.1. There are 10 significant KEGG
terms associated with those micrroRNAs from liver (Chen 2009). These top terms
include some keywords, such as diabetes and glycosaminoglycan degradation,
related to liver function, as they are metabolism related. This is discussed further in
the discussion section.
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Figure 3.4.1: The KEGG terms associated with the uploaded microRNAs primarily expressed in
liver.
3.5 CHRNA5 TARGETING MICRORNAS AND
THE ESTROGEN RECEPTOR
GSE15885 is a dataset comprising 29 early stage breast cancer samples and
expression of 353 microRNAs from this were investigated in this study in the context
of estrogen receptor status. The estrogen receptor (ER), progesterone receptor (PR)
and Human Epidermal growth factor Receptor (HER2/neu) expression status of the
samples were given. The SOFT formatted family files contained background
subtracted, median normalized and log transformed data.
By using the GEOquery library, a Biconductor package for R, the meta-data that
contain expression status of the aforementioned receptors, the normalized signal data
and the names of mature microRNAs were fetched to construct the mESAdb .csv file
format for upload. While labeling the samples only the estrogen status of the cells
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was considered. The uploaded file has been named 'GSE15885_er' and quantile
normalized.
The gene with ENSEMBL ID 'ENSG00000169684' is CHRNA5. The
microRNAs targeting it were queried in mESAdb underlying MySQL database where
the target information had been collected from the MicroCosm of ENSEMBL. The
release mESAdb has got 27 targeting microRNAs:
miR-106a, miR-106b, miR-126*, miR-137, miR-15a, miR-15b, miR-16,
miR-17, miR-20a, miR-20b, miR-220b, miR-223, miR-23a, miR-23b, miR-28-3p,
miR-301a, miR-301b, miR-409-3p, miR-424, miR-497, miR-520g, miR-554, miR-561,
miR-588, miR-607, miR-655, miR-93.
These microRNAs were saved in a text file to facilitate later selection. To see
how the samples project to two new dimensions that are captured top two highest
mean variability in the space of microRNAs, ‘motif & expression’ module of
mESAdb was used. After selecting the dataset, the list prepared previously was used
to select CHRNA5 targeting microRNAs. The result of correspondence analysis,
showing sample projections on to two dimensions based on variances of the selected
microRNAs in them, has been illustrated in Figure 3.5.1.
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Figure 3.5.1: The clustering of samples of GSE15885 dataset labeled according to only ER status
of the cells.
First of all, the most striking thing in this figure was the existence of
numerous clusters of samples. This separation also covers the discrimination of ER
positive and ER negative samples. Although a small number of samples violate the
trend, a line having approximately a 135 degrees angle with the x axis is separating
the estrogen positive and negative samples. The ER negative samples were observed
as three clusters in the Figure 3.5.1.
The figure from microRNA tab of the Correspondence Analysis output of the
mESAdb has been illustrated in Figure 3.5.2.
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Figure 3.5.2: CHRNA5 targeting microRNA clustering after correspondence analysis of
GSE15885 dataset.
The pattern observed in previously was also seen here. A line with
approximately 135 degrees with the x axis seemingly would cluster the microRNAs
such that every cluster could correspond to a sample cluster formed with the same
separating line. In this case, most of the microRNAs should be responsible for
clustering of ER negative samples. However, the Figure 3.5.3, which shows
corresponding groups will make the picture clearer.
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Figure 3.5.3: The correspondence tab of the output for GSE15885 dataset.
According to the figure, miR-15a, miR-15b, miR-16, miR-93 was clearly
related with ER positive samples. This also could be observed via expression
analysis of those micro-RNAs in the dataset. Figure 3.5.4 shows the result.
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Figure 3.5.4: The expression profiles of micoRNAs that are associated with ER positive samples
in GSE15885 dataset. Red bars indicate expression of the given set of microRNAs; height of the
bar refers to the magnitude of expression. There are more samples annotated by ps (positive)
than ng (negative) exhibiting red bars.
In this figure (Figure 3.5.4) we can clearly see that 11 out of 14 red bars are
belonging to ER positive samples (the ones with the ps_ suffix.). Three samples are
negative ones, ng_10, ng_9 and ng_13. To find out where theses microRNAs are
bound on CHRNA5 mRNA, microRNA.org (Betel, Wilson et al. 2008) was used.
The results are shown in Figures 3.5.5 and 3.5.6.
An mRNA can be controlled by numerous microRNAs either at one site or at
many sites. For the CHRNA mRNA, the case is the latter as could be seen in figures
3.5.5 and 3.5.6. Obviously it is not expected that all microRNAs that can potentially
suppress the CHRNA5 RNA are expressed at the same time. As a starting point, the
binding sites of CHRNA5 targeting microRNAs have been investigated through
microrna.org.
63
Figure 3.5.5: First part of the alignment that shows which microRNAs bind to which part of
CHRNA5 mRNA.
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Figure 3.5.6: Remaining part of the alignment that shows which microRNAs bind to which part
of CHRNA5 mRNA.
The two figures (Figure 3.5.5 and Figure 3.5.6) show the binding sites of
CHRNA5 targeting microRNAs. There are two major sites that collect most of the
microRNAs binding to the CHRNA5 mRNA. One of the sites is around 800th
nucleotide of the CHRA5 mRNA whereas the other is around 524th base. The case
has been tabularized in Tables 3.5.1 and 3.5.2.
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Table 3.5.1: The microRNAs having potential binding site around 524th base of CHRNA5
mRNA
microRNA Sequence Bindining site
hsa-miR-106b TAAAGTGCTGACAGTGCAGAT 526
hsa-miR-519d CAAAGTGCCTCCCTTTAGAGTG 526
hsa-miR-93 CAAAGTGCTGTTCGTGCAGGTAG 524
hsa-miR-106a AAAAGTGCTTACAGTGCAGGTAG 524
hsa-miR-17 CAAAGTGCTTACAGTGCAGGTAG 524
hsa-miR-20a TAAAGTGCTTATAGTGCAGGTAG 524
hsa-miR-20b CAAAGTGCTCATAGTGCAGGTAG 524
Table 3.5.2: The microRNAs having potential binding site around 800th base of CHRNA5
mRNA
microRNA Sequence Bindining site
hsa-miR-15b TAGCAGCACATCATGGTTTACA 802
hsa-miR-214 ACAGCAGGCACAGACAGGCAGT 802
hsa-miR-497 CAGCAGCACACTGTGGTTTGT 800
hsa-miR-15a TAGCAGCACATAATGGTTTGTG 800
hsa-miR-195 TAGCAGCACAGAAATATTGGC 800
hsa-miR-424 CAGCAGCAATTCATGTTTTGAA 800
hsa-miR-16 TAGCAGCACAGAAATATTGGC 799
The seed sequences of microRNAs in the first group are exactly the same,
AAAGTGC (Table 3.5.1). For the other group, the seed sequence is a motif,
AGCAG [C][G] [A][C] (Table 3.5.2). To discover any tissue specific groups of
microRNAs among those, correspondence analysis has been applied to three datasets
(Ach, Wang et al. 2008; Navon, Wang et al. 2009; Meiri, Levy et al. 2010) with
them. Results have been shown in Figure 3.5.7, Figure 3.5.8 and Figure 3.5.9.
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Figure 3.5.7: Projection of microRNAs that hit around 800th and 524th nucleotides of CHRNA5
mRNA according to the Ach et al, 2008.
According to the figure (Figure 3.5.7), except the five microRNAs all of them has
been accumulated together on to the space generated by the reduction of tissue space
of the Ach dataset to the two dimensions via correspondence analysis. The five
microRNAs showing divergence in expression have been miR-195, miR-497, miR-
214, miR-424 and miR-519d.
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Figure 3.5.8: Projection of microRNAs that hit around 800th and 524th nucleotides of CHRNA5
mRNA according to the Meiri et al, 2010.
A similar projection pattern has been produced by reducing the tissue space of the
Meiri dataset. There are differences and similarities between these figures Figure
3.5.8 and Figure 3.5.7. Again a bulk accumulation of microRNAs was seen in this
figure as it was seen in the previous one. This time the members of microRNAs that
were observed from the central part of the graphics were miR-20b, miR-214, miR-424
and miR-519d. The last three ones were common in both correspondence analyses for
the two datasets.
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Figure 3.5.9: Projection of microRNAs that hit around 800th and 524th nucleotides of CHRNA5
mRNA according to the Navon et al, 2009.
Projections of the two groups of microRNAs don’t show too much variability
and wide range distribution. Although Navon et al. 2009 dataset shows difference in
the view of microRNA set that formed major cluster in the previous two figures, the
general trend is the same such that miR-519d, miR-424 and miR-214 deviated from
the central point where all other microRNAs have tended to accumulate.
To find out if there is a consistent relationship between any microRNA and
tissue, the correspondence analysis has been applied to above datasets. Tissue-
microRNA correspondences for each dataset have been shown in the Figures 3.5.10-
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12.
Figure 3.5.10: Projections of microRNAs that hit around 800th and 524th nucleotides of
CHRNA5 mRNA and tissues according to corresponsence analysis of Ach et al, 2008.
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Figure 3.5.11: Projections of microRNAs that hit around 800th and 524th nucleotides of
CHRNA5 mRNA and tissues according to corresponsence analysis of Meiri et al, 2010.
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Figure 3.5.12: Projections of microRNAs that hit around 800th and 524th nucleotides of
CHRNA5 mRNA and tissues according to corresponsence analysis of Navon et al, 2009..
The only tissue common to all three datasets is the liver. So, from the given
figures, it is very difficult to infer any microRNA-tissue relationship. However,
Navon et al, 2009 (Navon, Wang et al. 2009) and Ach et al, 2008 (Ach, Wang et al.
2008) datasets have four common tissues, namely, breast, ovary, testicle and liver.
Considering this fact, from Figure 3.5.10 and Figure 3.5.13, it can be said that miR-
214 has a relation with ovary while miR-424 has a relation with testicle. To clarify
the results co-inertia analysis was applied to Ach et al, 2008 and Navon et al, 2009
with those microRNAs shown in the tables 3.5.1 and 3.5.2 by only selecting the four
common tissues. The result has been illustrated in the following three figures (Figure
3.5.13, Figure 3.5.14 and Figure 3.5.15).
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Figure 3.5.13: The distributions of common tissues on the two dimensions created by co-inertia
analysis of the two datasets, Ach et al., 2008 and Navon et al., 2009, with the microRNA set
listed in Table 1.3.1 and 1.3.2.
Although the RV coefficient was not very close to 1, the result of co-inertia
analysis was two projections where the projected locations of tissues were similar in
terms of their positions according to the origins of their maps. This means that a set
of similar covariance axes exist in microRNA spaces of both datasets. The
microRNA projections on to two dimensions derived from common tissue spaces of
both datasets via co-inertia analysis have been illustrated in Figure 3.5.14.
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Figure 3.5.14: Projections of microRNA data points after co-inertia analysis of both datasets,
Ach et al., 2008 and Navon et al., 2009, with their common tissues.
Expectedly, the three divergent microRNAs that have been determined in
Figures 3.5.7-12, miR-214, miR-424 and miR-519d again separated clearly from
others. In addition to those, another two member cluster has arisen, miR-195 and
miR-497 cluster (Figure 3.5.14).
In order to see the expression patterns of those microRNAs, cluster view
representing those microRNAs in minimum cluster number has been investigated. In
this trial, the minimum number that covers those microRNAs as separate clusters was
8. The case has been illustrated in Figure 3.5.15.
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Figure 3.5.15: K-means cluster output view of the projections of the microRNA data points
where K=8.
In this Figure (Figure 3.5.15), members of some cluster data points could
easily be recognized when it is compared to Figure 3.5.14. For example, cluster
number 1 represents the miR-519d. Accordingly, Cluster number 4 comprises only
miR-424 whereas cluster number 3 includes miR-214. Finally miR-497 and miR-195
have constituted the cluster 2 in this figure. As mentioned in section 3.2, those cluster
data points are clickable and if they are clicked, the expression patterns of cluster
members relative to out-of-cluster members are visualized in the datasets that are
subjected to co-inertia analysis via ‘expression & expression module’. So the facts
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about earlier inferences indicating the relationships between miR-214-ovary and miR-
424-testicle (Figure 3.5.10 and Figure 3.5.12) could be revealed by clicking on the
respective cluster points to see the cluster specific expression patterns. Following
figures (Figure 3.5.16, Figure 3.5.17, Figure 3.5.18 and Figure 3.5.19) show those
relationships as expression barplots.
Figure 3.5.16: Expression pattern of cluster point number 1 (Figure 3.5.15).
From Figure 3.5.13 and Figure 3.5.14 it is observed that miR-424 and miR-
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519d are relatively more expressed in testes than any other microRNA represented in
the Figure 3.5.14. Thus expression pattern seen in Figure 1.3.27 is expected as an
output of expression analysis of cluster 1 seen in Figure 3.5.15.
Figure 3.5.17: Expression pattern of cluster point number 4 (Figure 3.5.15).
This figure has been generated via mESAdb by clicking the cluster number 4
illustrated in the Figure 3.5.15. Previous observations from Figure 3.5.10, Figure
3.5.11 and Figure 3.5.12 stating that miR-424 expression has been related to testes
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was supported by this figure (Figure 3.5.17) as it could be done by comparing the
locations of tissues and microRNAs from Figure 3.5.13 and Figure 3.5.14. In those,
it is again seen that location of testes corresponded to the location of miR-424.
Figure 3.5.18: Expression pattern of cluster point number 3 (Figure 3.5.15).
In a similar way, Figure 3.5.18 shows the miR-214-ovary relation as Figure
3.5.17 did between miR-424 and testes. Again, they were one of the consistent co-
localized microRNA-tissue couples that have been observed in Figure 3.5.10, Figure
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3.5.11 and Figure 3.5.12.
Figure 3.5.19: Expression pattern of cluster point number 2 (Figure 3.5.15).
Restricting the co-inertia analysis to the common tissues between the two
datasets created another microRNA cluster that is separated from the group seen as a
bulk accumulated close to the origin in the +/+ area of the axes illustrated in the
Figure 3.5.14. Comparison of locations of cluster number 2 and locations of tissues
from Figure 3.5.15 and Figure 3.5.13 respectively reveals that location of the new
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cluster is closer to breast tissue than any other tissues in Figure 3.5.13 where those
figures are the outputs of the same co-inertia analysis. Figure 3.5.19 supports those
observations. Furthermore, the very short distance between the clusters 2-3 implies
that members of both clusters could be enriched in the ovary. This figure supports
also this observation. We see red bars only in two tissues in Figure 3.5.19, breast and
ovary.
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CHAPTER 4:DISCUSSION
mESAdb is a meta-analysis tool based on a database which has been built via
integration of a multitude of resources relevant to microRNA biology. Main features
of mESAdb can be listed as followings: I-) User specific high-throughput microRNA
expression data upload utility; II-) Comparisons of two high-throughput microRNA
expression datasets via coinertia analysis; III-) Sequence-expression relationship
analysis for microRNA lists; IV-) Expression analysis for one or a group of
microRNAs; V-) Functional annotation for one or a group of microRNAs via GO,
KEGG and HuGE databases based on their targets stored in MicroCosm.
For a meta-analysis tool, providing user specific data upload is an important
feature. First of all, users can re-annotate the microRNA probe sequences according
to up to date miRBase (Ambros, Bartel et al. 2003; Griffiths-Jones 2004; Griffiths-
Jones, Grocock et al. 2006; Griffiths-Jones, Saini et al. 2008; Kozomara and
Griffiths-Jones 2011) nomenclature while uploading the data. It has been made
possible to normalize the uploaded data as requested using quantile normalization.
Similarly, linearization of illumination intensity data via log transformation also is
made possible. Those novel features enable comparison of the uploaded data with the
existing ones in the database in a uniform way.
Uploaded datasets can be analyzed in different manners: For example if a
cancer dataset is uploaded such as the one exemplified in Section 3.1.1 and Figures
3.1.1-3, mESAdb could help test the similarity among different patient samples in
terms of the tissue specific microRNA expression using multivariate analyses such as
correspondence analysis and co-intertia analysis. In the case study exemplified here
in the Section 3.1 By selecting ‘AAGTGC’ seed motif, found to be human
embryonic stem cell specific by Laurent et al., 2008, mESAdb has separated most of
the samples with hepatocellular carcinoma from others as clusters (Figure 3.1.2).
This is actually plausible since earlier it has been reported that cancer cells have a
hierarchy of organized groups of malignancies in which only a rare subset of cancer
cells drives the tumor growth (Brennecke, Stark et al. 2005). Nevertheless CSCs
(Cancer Stem Cells) have also been described in HCC (Krek, Grun et al. 2005). None
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of the microRNAs listed in Table 3.1.1 has been reported as liver cancer stem cell
specific miccroRNAs in the literature, although a comprehensive study has been
done on this subject recently (Lewis, Burge et al. 2005). According to the
distribution of projections of the microRNAs in the Table 3.1.1 on the same space on
which samples from hcc patients and normal livers have been projected (Figure
3.1.3) except the miR-520b and miR520f, all microRNAs are co-localized with
different hcc clusters.
Though, possible clusters of samples might also be associated with the
clinical annotation of samples to deduce whether tissue expression patterns of the
selected microRNAs are correlated with a given set of patients or controls. In that
case we could investigate the direction of projections of expression values of
microRNAs like it has been done for across species dataset (Figure 3.2.2).
To solidly demonstrate this aspect of mESAdb is to enable comparative
analysis of microRNA expression patterns across taxa. To exemplify in the results
section we compared a mouse and a human dataset (Thomson, Parker et al. 2004;
Meiri, Levy et al. 2010) (Figure 3.2.1). The microRNA list was composed of let-7a-i,
mir-130a-b, mir-15a-b, mir-181a-b, mir-200a-b, mir-23a-b, mir-26a-b, mir-29a-c,
mir-30a-d and mir-99a-b clusters (Table 3.2.1, Table 3.2.2 and Table 3.2.3) and
expression was studied across taxa for the brain (B), liver (Li), lung (Lu), kidney (K)
and heart (H). The high RV coefficient, ~0.730, indicated that the mouse and human
expression data for the abovementioned tissues and microRNAs were highly
comparable and similar. Interestingly, the RV coefficient for the selected
microRNAs is much higher than the one, generated by the selection of all available
microRNAs with the same tissue set (~0.464; not reported earlier). This suggests that
selected microRNAs could be functionally more conserved between the two taxa.
Among the conserved microRNAs, one pair is miR-181a and miR-181b. In
the literature, both mir-181a and mir-181b were shown to be tumor suppressors in
glioma where mir-181b were more effective than the former (Shi, Cheng et al. 2008).
mESAdb analysis has shown that in both mice and humans, miR-181a and miR-181b
were more abundant in brain and also in lung than in the other tissues. This tissue
specificity is in support of their function in human gliomas and our findings suggest
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that these microRNAs might also be involved in tumor suppression of mouse brain
cancers. miR-181a also was recently implicated in the prognosis of non-small cell
lung cancer (Gao, Yu et al. 2010).
mESAdb phi-coefficient analysis of miR-200a and mir-200b in these mouse
and human expression datasets also revealed that these two microRNAs have very
highly similar expression patterns as expected since they have similar sequences.
Their higher expression in Kidney, Liver and Lung but lower expression in Brain and
Heart suggested that they exhibited epithelial cell specificity. Indeed, previous
research has shown this was the case (Bracken, Gregory et al. 2008). The findings in
addition showed that their expression was similar also among taxa, suggesting results
obtained from animal models for miR-200a-b might be extended to human
pathogenesis. In recent literature, miR-200a and miR-200b were up-regulated
simultaneously in a rat model of diet-induced nonalcoholic fatty liver disease
(NAFLD) (Alisi, Da Sacco et al. 2011). Since expression pattern of miR-200a and
miR-200b in mouse and human is highly conserved, these two microRNAs also
might be involved in the pathogenesis of human NAFLD. Furthermore, miR-200a
and miR-200b were shown to be up-regulated intrarenally in hypertensive
nephrosclerosis, in accord with the expression of miR-200a-b in kidneys of mice and
humans (Wang, Kwan et al. 2010).
mESAdb as a meta-analysis tool and database focuses also on discovery of
associations between microRNA sequence and expression. mESAdb is advantageous
because it allows interactive analysis of selected subsets of microRNAs in addition to
analysis of single microRNA types. The sequence and expression relation is
important because microRNAs exert their functions through their seed sequences,
generally between 2nd and 7th bases from 5’ end of the mature RNA, through binding
multiple sequences located in 3’ UTR or any other part of mRNA of the target gene
to be silenced via base complementation. This base complementation is partial most
of the time and same target sequences could be found in thousands of genes. So a
motif that describes those target sequences might point to a systemic expression
profile change. Such an important relation can be surveyed through mESAdb in two
ways: 1) For instance, as mentioned in the result section, miR-181a and miR-181b,
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similar in their mature sequences differing only in 3 nucleotides, (Table 3.2.3)
exhibit a common sequence motif (i.e. AACATTCA) in their first 8 nucleotides. The
mature sequences miR-200a and miR-200b are also containing a common motif (i.e.
TAA[C][T]ACTG) in their first 8 nucleotides (Table 3.2.3). Those a-b couples are
very close to each other in both genomes (Table 3.2.1 and Table 3.2.2). This may be
the reason of their expression similarity seen not only in the Figure 3.2.2 but also
seen in the Figure 3.2.3.
A broader set of examples of these aforementioned cases and more have been
illustrated in section 1.3.5 on CHRNA5 targeting microRNAs. There are increasing
number of studies that relate nicotine and estrogen (Biegon, Kim et al. 2010; Lee,
Chang et al. 2010; Si, Long et al. 2010; el-Mas, el-Gowilly et al. 2011; Kandi and
Hayslett 2011; Wang, Zhao et al. 2011; Yararbas and Pogun 2011). Also there has
been a study indicating that a SNP in CHRNA5 gene, rs16969968, significantly
alters the nicotine dependence of the smoker (Sherva, Wilhelmsen et al. 2008).
Furthermore, it has been shown that chromosome 15q24-25.1 is a significant lung
cancer susceptibility region in which CHRNA5, CHRNA3 and CHRNB4 genes are
allocated. In the results section, the relationship between CHRNA5 targeting
microRNAs and estrogen receptor expressing breast cancer samples has been
assessed using the GEO dataset GSE15885 (Lowery, Miller et al. 2009).
Correspondence analysis has indicated that miR-15a, miR-15b and miR-16,
(Figure 3.5.1, Figure 3.5.2 and Figure 3.5.3) were highly expressed in ER positive
samples than they were in ER negative although these three microRNAs did not
explain the variability 100%. Indeed, miR15a, miR-5b and miR-16, sharing common
seed sequence cluster together, hence potentially target the same genes. All in all, it
has been shown that miR-15 / 16 family targets BCL-2 (Cimmino, Calin et al. 2005),
which is involved in regulation of apoptosis and thus might generate prognostic
differences between ER negative and ER positive breast cancer patients.
In the CHRNA5 example, it has been used two groups of microRNAs, each
with a common seed sequence within the group (Figure 3.5.5: First part of the
alignment that shows which microRNAs bind to which part of CHRNA5 mRNA.
and Tables 1.3.4-5). One of the groups has a binding side starting from 524th
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nucleotide of the mRNA, whereas the other group has one starting at 800th base.
These two groups did not show a consistent and tight separation in terms of
expression variability in the reduced tissue space throughout different datasets
(Figure 3.5.7, Figure 3.5.8 and Figure 3.5.9). However three of the microRNAs that
target CHRNA5 were found to be consistently divergent in expression based on the
correspondence analysis results. Those microRNAs were miR-214, miR-424 and
miR-519d (Figure 3.5.7, Figure 3.5.8, Figure 3.5.9, Figure 3.5.10, Figure 3.5.11,
Figure 3.5.12 and Figure 3.5.14). In Figure 3.5.10 and Figure 3.5.12, it could be seen
that miR-214 was coupled with ovary and miR-424 was coupled with testes. Co-
inertia analysis based on Ach et al., 2008 and Navon et al., 2009, showed that the
above relationship was consistent across datasets (Figure 3.5.18 and Figure 3.5.19).
Also, according to the Ach dataset miR-519d was found to be placenta specific
(Figure 3.5.10). In addition, two other microRNAs, miR-195 and miR-497 were
shown to be breast and ovary specific (Figure 3.5.19).
Accordingly, use of mESAdb has allowed identifying the CHRNA5 targeting
microRNAs that show tissue specificity. This feature of mESAdb can help
researchers to pinpoint a smaller subset of microRNAs among a large number of
potential candidates. In fact, a new study suggested that there are 8 microRNA genes
regulating p21 on the 19q13 in human genome where the largest human microRNA
cluster exist with 46 members (Wu, Huang et al. 2010). They also state that it is the
combined action of the eight microRNAs that is regulating p21 gene efficiently.
They also identified other microRNAs through screening of the ones predicted by
numerous microRNA prediction tools. By summarizing these facts, it has been
reported in a review that the combination of microRNA targeting same gene should
be studied instead of studying one microRNA-one mRNA connection (Peter 2010).
Similarly the consistent tissue pairing shown by these 5 microRNAs targeting
CHRNA5 on either of the two regions may reflect this fact. Hence these relations
mentioned in the result chapter were surveyed in the literature.
The most studied microRNA among them is miR214 (Flynt, Li et al. 2007;
Li, Flynt et al. 2008; Yang, Kong et al. 2008; Chan, Yue et al. 2009; Juan, Kumar et
al. 2009; Yang, Chen et al. 2009; Chen, Shalom-Feuerstein et al. 2010; Jindra,
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Bagley et al. 2010; Juan and Sartorelli 2010; Liao, Du et al. 2010; Liu, Luo et al.
2010; Zhang, Ye et al. 2010; Bar-Eli 2011; Denby, Ramdas et al. 2011; Feng, Cao et
al. 2011; Narducci, Arcelli et al. 2011; Penna, Orso et al. 2011; Qiang, Wang et al.
2011; Sehic, Risnes et al. 2011) with 19 publications. One study shows that miR-214
promotes cell survival and resistance to cisplatin by targeting the PTEN hence by
activating the Akt pathway in ovarian cancer (Yang, Kong et al. 2008). This
evidence is in concordance with the tissue specificity of miR-214 in ovary and to
some extent in breast. Another study has shown that miR-214 regulates the
expression of a protein, lactoferrin (lf), which is abundant in human milk in
mammary epithelial cells (Liao, Du et al. 2010). In the same study it has been also
shown that as the amount of miR-214 inhibitor is increased in MCF7 cells; activity
of caspase3 and lf amount is relatively elevated.
The literature search for the members of newly emerged cluster consisting
miR-195-miR497 produced 11 hits (Soon, Tacon et al. 2009; Xu, Zhu et al. 2009;
Gonsalves and Kalra 2010; Liu, Chen et al. 2010; Sekiya, Ogawa et al. 2010;
Ujifuku, Mitsutake et al. 2010; Yin, Deng et al. 2010; Li, Zhao et al. 2011; Wang,
Wang et al. 2011; Zhu, Yang et al. 2011; Zhu, Zhu et al. 2011). Accordingly, miR-
497 targets BCL-2 hence triggers apoptosis (Yin, Deng et al. 2010; Zhu, Zhu et al.
2011). According to literature, miR-195 has been defined mainly as a tumor
suppressor gene (Xu, Zhu et al. 2009; Liu, Chen et al. 2010; Sekiya, Ogawa et al.
2010; Wang, Wang et al. 2011). Both miR-195 and miR-497 resides on 17p13.1 as a
cluster and they have been declared as potential tumor suppressors previously
(Flavin, Smyth et al. 2009). Furthermore, it has been shown that in breast cancer
patients this cluster is down regulated (Li, Zhao et al. 2011). This may suggest that,
although there is no reported tissue specificity for those microRNAs, they may
function in breast tissue as anti-apoptotic fine tuning microRNAs. miR-424 does not
have any known tissue specificity. There are a couple of studies stating that miR-424
is involved in monocyte differentiation (Rosa, Ballarino et al. 2007; Forrest,
Kanamori-Katayama et al. 2010). Also it has been reported that down regulation of
miR-424 contributes to abnormal angiogenesis (Nakashima, Jinnin et al. 2010).
Although miR-424 is not the focus of any study relating it to testes, it has been
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reported as differentially expressed between mature and immature testes of porcine
(Luo, Ye et al. 2010). Putting everything together, a study that researches the
function of miR-424 in testes would be interesting.
mESAdb is modular. Its each module has a different function so far outputs
only from the ‘expression & expression’ and ‘motif & expression’ modules have
been discussed. Another interesting finding using mESAdb showed the potential of
mESAdb to associate a group of micorRNAs with a group of disease using its ‘motif
& function’ module. In the example given in Figure 3.3.3, liver specific microRNAs
were searched against the HuGE database in terms of their targets. The finding that
this set of microRNAs being significantly associated with mainly liver diseases (e.g.,
Hepatitis A-E) is striking and suggests that microRNA disease connection might be
effectively resolved using an approach we used in the mESAdb. In connection with
the liver specific microRNAs other diseases also showed up as significant, such as
ClubFoot and Cleft palate. What could be the association of liver specific
microRNAs with diseases of the cartilage/bone should be further assessed.
Interestingly, in the literature, liver steatosis has previsouly been associated with
multiple symptoms including club feet (Elliott, Meagher-Villemure et al. 1996).
What makes mESAdb unique is its ability to analyze user data together with
default datasets via different modular aspects of expression analysis, such as
histograms and multivariate analysis. Previous microRNA databases also have
implemented different combinations of barplots and heatmaps (Betel, Wilson et al.
2008; Nam, Kim et al. 2008) but the inclusion of multivariate analysis tools such as
correspondence and co-inertia analyses into microRNA expression analysis is novel
among microRNA expression databases. For example, miRGator (Nam, Kim et al.
2008) represents tissue expression data in the form of barplots and boxplots.
Similarly, mESAdb uses barplots but also visually illustrates selected and non-
selected microRNAs allowing comparison between their expression patterns.
mESAdb enables multiple tissue and microRNA selection prior to the analysis.
These selections create relative p-values for the calculated tissue enrichments
according to the selections, a case that could create different biological questions.
Another commonly used resource microRNA.org (Betel, Wilson et al. 2008) enables
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the sample addition while viewing the barplots or heatmap based on a java
application that represent expression levels for each microRNAs; however, it does
not allow sequence based microRNA group selection. microRNA.org enables
multiple selections if microRNA-target expression comparisons are requested.
mESAdb also provides versatile selection of multiple microRNAs via either its
intrinsic selection tools or file upload. In mESAdb, graphical representations are not
dynamic as it is in microRNA.org however they are R based. Accordingly, graphical
representation is not limited to barplots and heatmaps, and enables viewing tissues
and microRNAs on reduced dimension with two axes using MADE 4 package.
Neither miRGator nor microRNA.org enables expression comparison across
species. This is a feature unique to mESAdb currently. This is made possible by
using dimension reduction methods provided by made4 R package (Culhane,
Thioulouse et al. 2005). On-the-fly application of K-means algorithm to the mean of
the projected coordinates of microRNAs is also a unique feature of mESAdb.
Additionally, mESAdb allows for high-throughput user data upload, an advantageous
feature allowing for comparison of user specified data with existing datasets. And to
our knowledge, mESAdb is currently the only database that has integrated HuGE
phenopedia and genopedia to current microRNA data warehouse.
In summary, versatile input and output methods provided by mESAdb allows
production of flexible biological questions.
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CHAPTER 5:FUTURE EXTENSIONS
5.1 MESADB
Modular nature of mESAdb allows for incorporation of additional data sets
and statistical tools. Regarding this flexibility, future extensions to mESAdb will
start with building a function that could automatically add microarray data sets from
GEO. It is also planned that client specific on-the-fly class renaming will be possible
for uploaded datasets regardless of the source.
Classification of uploaded datasets according to human pathogenesis is also
planned. Especially, inclusion of a group header particularly focusing on cancer has a
priority in an improvement of this kind. The infrastructure will be based on keywords
constructing the MIAME (Brazma, Hingamp et al. 2001) standards. It is also planned
to analyze a given set of cancer related microRNA datasets using graph properties
and meta-analysis tools as exemplified in the following section on ARC.
One of the main features that makes the mESAdb unique among the
microRNA expression databases is the possibility of selecting a subset of genes
according to their sequence properties. An additional improvement is intended also
in this area. Since there are non-conserved functional microRNA binding sites (Tay,
Zhang et al. 2008) and new emphasis put on multiple microRNA control over one
mRNA theory (Peter 2010), understanding which set of microRNAs play a role in
which particular tissue(s) has become an important concern. In order to do that
addition of predicted target specific microRNA lists (e.g., as done for CHRNA5 in
the results section) to the microRNA selection list criteria is planned. While
providing this, the option of selecting the target source, i.e., PicTar or miRanda will
be available. In other words, the set of target microRNA association won’t be
restricted to Microcosm.
Use of R packages enhances the modular nature of the mESAdb thus future
addition of statistical and visual tools for sequence/expression/function analysis of
microRNAs also is planned. For example, incorporations of meta-analysis tools such
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as metaGEM (Ramasamy, Mondry et al. 2008) and MAMA (Ihnatova 2010) will
enable to user to apply meta analysis for more than two datasets.
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5.2 AN EXTENSION OF THE FRAMEWORK
USED IN MESADB TO OLIGONUCLEOTIDE
DEALING WITH CANCERS: ARC
In this section we present an ongoing effort in combining mESAdb with
another database, which we name ARC (Annotation and Regulation of
Coexpression), focusing on mRNA microarray data analysis. This is important to
increase the comprehensive nature of mESAdb and to be able to make associations
between microRNAs and mRNA target expression. In this new framework ARC,
uses a similar framework as mESAdb and microarray datasets focusing on human
cancers, mostly breast and colon cancers, and a series of zebrafish tissues and
experiments are used. The advantages of the framework used in mESAdb and ARC
are: flexibility in terms of integration of new data types due to its modular structure;
power of the statistical environment R in analyzing different types of data together
and power of MySQL in storing various types of datasets; use of databases such as
ENSEMBL, one of the most important genome browsers, that can be downloaded
and installed as mysql databases; use of PHP and JavaScript to create tools easy to
use and ones on which on-the-fly high throughput data analyses are possible.
Although an ongoing project, ARC will briefly be introduced herein and then
the future perspectives for mESAdb and ARC will be presented. ARC aims to
investigate a given set of gene probesets identifying a group of genes in different
mRNA microarray datasets, i.e., from cancer patients or cancer cell lines treated with
agents and zebrafish tissues and developmental series (e.g., cluster a group of
pobesets; annotate a probeset with a function). ARC will serve to integrate similar
human and zebrafish datasets and allow for simultaneous analysis across taxa as
demonstrated in mESAdb. In the following two sections, the ARC modules shortly
will be described.
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5.2.1 Clustering module of ARC
Figure 5.2.1: The view of the main page of tool developed for the analysis of oligo arrays.
The aim of the tool is to analyze/visualize a given set of mRNAs (probesets
from Affymetrix platforms from human and zebrafish) selected by user, based on
KEGG anotations or Huge Navigator terms. The main page of the tool (Figure
5.2.1Hata! Başvuru kaynağı bulunamadı.) allows for dataset selection based on
four different criteria: species (i.e., human, zebrafish), array platform (i.e.,
HGU133A, HGU133 plus 2, Gene Chip Zebrafish), normalization (i.e., MAS5,
RMA, GRSN COMBAT) and tissue type (i.e., breast, colon, pancreas, bladder).
Selected datasets incorporated into this new database have raw datasets available,
thus allowing for user-defined normalization. The selection criteria for normalization
types seen on the main page of the tool allow for analysis of different datasets using
different normalizations (Figure5.2.1Hata! Başvuru kaynağı bulunamadı.). The
normalization types listed in the selection list on the main page are MAS5.0
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(Affymetrix 2001), RMA (Irizarry, Hobbs et al. 2003), GRSN (Pelz, Kulesz-Martin
et al. 2008) and ComBat (Johnson, Li et al. 2007).
The selections made in the main page are directed to two separate pipelines:
cluster analysis and annotation analysis (Figure 5.2.1Hata! Başvuru kaynağı
bulunamadı.). Both have a gene selection/entry bridge pages. For example, when all
breast cancer datasets normalized with RMA are directed to cluster analysis pipe the
gene entry page below appears.
Figure 5.2.2: Snaphot of gene selection page at the beginning of cluster analysis pipe.
In the gene selection page (Figure 5.2.2Hata! Başvuru kaynağı
bulunamadı.) there are four options to enter genes of interest. On the bottom left
side of the page there is a text box, and two of the options are directly entering the
genes into it either by their symbols or probeset names representing them. The
remaining two options are automatic incorporation of probesets linked with either a
HuGE term or a KEGG pathway into the text box area. Both HuGE and KEGG terms
are long lists. Thus, to ease finding of desired term, a key word entry box has been
linked to the lists. When a word is typed; the long list becomes short and this
shortened list includes the words bearing only the key one entered. In the Figure
5.2.2Hata! Başvuru kaynağı bulunamadı., this option has been illustrated by using
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the keyword “breast”. The keyword eliminated to list to four huge terms, “Breast
disease”, “Breast diseases”, “Breast Neoplasms” and “Ductal, Breast”. Among them
the term “Breast Neoplasms” has been selected. Hence the gene entry box has
automatically filled with the probests representing genes linked to “Breast
Neoplasms” according to the HuGE database.
The output of the cluster analysis after submission is as illustrated in Hata!
Başvuru kaynağı bulunamadı..
Figure 5.2.3: A snaphot of the cluster analysis output.
The heat maps and cluster figures generated by combination of Cluster 3 of
Eisen lab (Eisen, Spellman et al. 1998) and Bioconductor package Heatplus (Ploner).
5.2.2 Annotation Module of ARC
There are numerous genes in the human genome with known coordinates and
sequences yet with no association to a metabolic or signaling pathway or functional
terms (e.g., KEGG pathway). One of the powerful and de novo strategies to annotate
a gene/probeset with a functional keyword has been to find expression neighbours of
that particular gene and calculate the functional enrichment of the neighbouring gene
set with respect to the whole genome/chip (Trupti Joshi ; Srivastava, Qiu et al. 2010).
Examples for novel gene annotation include PubLiME using graph based approaches
for co-occurring genes (Finocchiaro, Mancuso et al. 2007), GlobalAncova where
gene sets are tested against others using general linear models (Hummel, Meister et
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al. 2008), IntelliGO that uses new semantic indices for defining gene function
(Benabderrahmane, Smail-Tabbone et al. 2010), disease candidate gene prioritization
algorithms based on protein-protein interaction networks (Chen, Aronow et al. 2009;
Chen, Yan et al. 2010). In the literature there are several examples: TOPPgene
allows for association of gene lists with other gene lists using training and a test lists
(Chen, Xu et al. 2007; Chen, Bardes et al. 2009). Other novel gene function
predictors that use large scale multiple expression studies together with other
information resources include Genemania (Montojo, Zuberi et al. 2010) where
queried gene is associated with other using using a guilt-by-association approach and
TranscriptomeBrowser that uses a clustering algorithm to extract transcription
signatures (Lopez, Textoris et al. 2008), and mSigDB where a gene(s) could be
associated with another gene list or functional term (Liberzon, Subramanian et al.
2011).
There is still however a need for a meta-analytic approach in gene
prioritization and novel gene annotation in the context of conserved cancer genes
(e.g., across taxa). Obtaining meta-indices for functional annotation across a series of
related experiments increases the power of association obtained from a single study.
In ARC, an approach has been used in which a given gene/probeset(s) was associated
with a KEGG pathway term based on the ranked correlation between the sample
similarity matrix of the queried gene(s) and that of the target gene set (i.e., KEGG
pathway set). A modified RandProd (Breitling, Armengaud et al. 2004) algorithm,
which is a nonparametric meta-analysis method for microarray datasets (Hong,
Breitling et al. 2006), has been adopted to be able to associate an unannotated
gene/probeset(s) with a KEGG pathway term (KEGG Pathway Maps, March 2011)
across a given set of related experiments (Appendix 7.2, Table 7.2.1). Original
RankProd by (Breitling, Armengaud et al. 2004) is based on ranking of fold
differences between two classes. The meta-analysis version of the RankProd
algorithm (Hong, Breitling et al. 2006) uses the products of the ranked fold
differences across a given number of studies. A permutation based p-value is then
assigned for testing significance.
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In our study, the analysis is not restricted to two groups since no fold change
needs to be calculated; instead a ranked association index is calculated based on the
correlation between two matrices, each of which is made up of eucledian distances
between samples based on either the expression values of the queried gene(s) or
those of the targeted gene(s) (i.e., KEGG pathway set). The correlation values
between the expression matrices of the queried and targeted gene sets are then
inverse-ranked; the product of these ranks is used as the combined rank of the studies
under investigation. A p-value is calculated based on 100 randomly shuffled data
matrix (both KEGG indices and the experimental study indices are permuted) that
contain the original inverse-ranked correlations. A list of KEGG terms and the
associated rank products are provided as the output of this module; only those terms
with a p-value less than 0.05 are shown. The correlations between the queried and
targeted gene sets as well as their inverse ranks together with the associated p-values
obtained from permutations also are provided as .xls files and are downloadable. The
tool is now available for looking up a probeset(s)/gene(s) present in several
Affymetrix Gene expression Analysis profiles for human and zebrafish with a focus
on mostly colon and breast cancer studies (Table 5.2.1). The user can select any
number of the available datasets and associate a gene(s) with each of the maximum
possible number of different KEGG terms available for the selected platform across
selected studies and obtain also a short list of KEGG terms that are significantly
associated with the given gene.
For example, it is possible to associate a gene with known functions in one
biological process to see what other pathways this gene might be involved in. After
selecting all breast cancer datasets pre-processed with RMA normalization,
CHRNA5 was entered in to the gene box in the gene selection page for annotation
analysis (Figure 5.2.4).
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Figure 5.2.4: Gene selection page for annotation analysis.
Upon clicking the submit button, the probeset (or gene) entered is associated with
KEGG pathways through a rank based comparison done based on expression values
(see above for algorithm) across selected studies. This is a meta-analysis tool that
allows for association of an unknown gene with a given set of lists, in this case the
KEGG pathways lists. An example is given for CHRNA5 probeset. This gene’s
expression was mostly associated with ErbB signaling pathway. The output of such a
submission has been illustrated in Figure 5.2.5.
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Figure 5.2.5: A snapshot of annotation analysis result.
5.3 FUTURE PERSPECTIVES ON COMBINING
MESADB WITH ARC
In the future zebrafish and human modules of ARC will be integrated and
comparative analysis of zebrafish and human mRNA datasets will be possible for an
evolutionarily conserved set of genes. Furthermore, the connection between mESAdb
and ARC will be established. The advantages of being ARC and mESAdb interacted
will then enable the user to study the mRNA and microRNA expression studies
simultaneously and comparatively and also across different taxa. Furthermore, the
annotation algorithm of the ARC can be applied to gene lists other than KEGG. One
possibility is to include the gene lists that are targeted by a particular microRNA.
Accordingly, it will be possible to test whether a set of genes targeted by a
microRNA(s) are co-expressed and/or associated with a given gene list or functional
term. In addition, the MADE4 tools used in mESAdb will be applied to the
framework in ARC to establish synchronization and potentially analyze microRNA
expression patterns with mRNA expression patterns in a user-specified manner.
Addition of new datasets into mESAdb and ARC are also planned to
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comprehensively analyze cancer datasets. A full integration of zebrafish Affymetrix
microarrays is also planned. We also aim to integrate the rank product based
annotation module used in ARC and other related meta-analysis tools that exist in the
literature into mESAdb framework. This addition will allow to obtain combined
statistics on microRNA expression values across different studies for a given tissue
or experimental class and will help generalize results from expression profile
analyses performed in mESAdb.
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CHAPTER 7:APPENDIX
7.1 TUTORIALS ON HOW TO USE MESADB
7.1.1 Protocols:
7.1.1.1 Motif & Expression
1) Select a dataset from the list
2) Select a group of microRNAs either by manual entry, or through
uploading a list of microRNAs or entering a sequence motif in IUPAC
alphabet to search for.
3) Select one of the three analysis options: expression analysis,
correspondence analysis, or co-inertia analysis
a. If expression analysis is selected, the resulting output page will
contain a bar graphic in which the selected microRNA expression
level is indicated with respect to that of the unselected
microRNAs in the different tissues. Each bar is color coded by
using a phi-coefficient indicating the enrichment (red) or depletion
(green) of the selected microRNAs in the given tissue. The
expression data can be retrieved as a table.
b. If correspondence analysis is selected, a page with three tabs will
come up. The tabs are ‘Tissues’, ‘miRNAs’ and
‘Correspondence’. The figure represented in ‘tissues’ tab shows
projections of tissues onto a new reduced common covariance
space of tissues and microRNAs. The tissues are represented by
one to three letters. To see the full names of the tissues, putting the
mouse arrow on the letters is necessary. If the ‘miRNAs’ tab is
selected, the figure show projections of microRNAs on to the
same space. Finally ‘Correspondence’ tab is for visualizing the co-
localization of the previous two figures. Closer the microRNAs or
tissues in space to each other the closer they are in expression
patterns.
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c. If co-inertia button is clicked the output will be a two-tabbed
result page. Two figures that appear in ‘Tissues’ tab shows the
correspondence between the tissues and the seed motifs obtained
from MEME, a motif finding algorithm.
7.1.1.2 Expression &Expression
1) Select a dataset from the left box and send it to the box on the right with
the arrow button between two boxes. Do it for a second dataset. Then
click the submit button.
2) Select a group of microRNAs either by manual entry, or through
uploading a list of microRNAs or entering a sequence motif in IUPAC
alphabet to search for. Click on ‘Co-inertia Analysis’. Two tabs are
available: Tissues and miRNAs. In tissues, how two datasets compare to
each other with respect to expression in tissues will be shown using
MADE 4.0 program. The other tab, ‘miRNAs’ shows how projected
microRNAs diverged between two datasets on the common space. The
tails of the arrows represent projections from the first dataset and the
heads of the arrows represent the projections from second dataset. The
miRNA tab has three sub tabs. They are ‘Labeled’, ‘Unlabeled’ and
‘Clustered’. ‘Labeled’ and ‘Unlabeled’ sub tabs are for showing or hiding
the labels holding the names of microRNAs represented by the arrows.
‘Clustered’ tab is the output of K-means clustering of projections with
minimum silhouette, for k in 2 to 10. The cluster number that shows the
lowest silhouette will be the default number of clusters chosen
automatically. A select box exists on the left top site of the page shown in
this sub tab for selecting the different clustering for each K. The resulting
page will have an extra tab called ’Heatmap’ that shows the hierarchical
clustering of the two datasets in terms of genes and classes i.e., tissues,
accompanied with the heatmap representing relative expression values
that are mean subtracted. Red color means that the value above 0 whereas
green color means that the value is below 0.
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7.1.1.3 Motif & Function
1) Select an organism. There are three possibilities: Homo sapiens, Mus
musculus and Danio rerio.
2) Select the method of microRNAs from selection box ‘select miRNA
upon’ by specifiying dinucleotide motif, or through uploading a list of
microRNAs or entering a sequence motif in IUPAC alphabet to search
for. Except for the file upload option, determine a region where the motif
should be present. Then click Submit.
3) Resulting page will show you ‘GO terms’, ‘HUGE terms’ and ‘KEGG
pathways’ buttons. ‘HUGE terms’ button is only available for Homo
sapiens. In the next line a selection bar for GO term type is present. If GO
term analysis is considered, selection of the desired ontology type is
required. Last line of this page is a tab called ‘Click to see miRNAs’. If
this tab is clicked, the selected list of microRNAs will appear, with a
download option for getting their mature sequences in FASTA format.
Each microRNAs in the list is clickable to direct the client to a page
where the targets of it could be seen. This option is extended in following
relevant section.
4) The resulting page will show four columns. First column is a Term ID
column depends on the source selection for the term, i.e., HuGE ID.
These IDs are clickable and directs the user for the original source page.
The second column is ‘Term Name’ column. The list and the header of
the column are specific to the term source. Third and forth columns are
representing the genes targeted by the selected microRNAs and P-values
that show the significance of the terms determined by the target genes
respectively. All in all, the result page shows that whether the selected
microRNAs are associated with significant GO terms, HUGE terms or
KEGG pathways. The results are downloadable as tab delimited text file
format.
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7.1.1.4 MicroRNA search
1) Enter a mature microRNA ID.
2) Select an organism.
3) In this section one can analyze whether the selected microRNA is
associated with a functional term (i.e., GO, HUGE or KEGG) or
which targets it has or what kind of expression it has in a selected
expression dataset. The figures and results pages are as described
before in the motif-expression, expression-expression, and motif-
function modules.
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7.2 ARC TABLES
Table 7.2.1: Datasets used in ARC.
Name of the Study Reference Organism/Tissue
# of
Samples
Normalization
Integrative Genomic and Proteomic Analysis of Prostate
Cancer Reveals Signatures of Metastatic Progression
(GSE3325)
(Varambally, Yu et al.
2005)
Human/Prostate 19 RMA
Molecular Marker for predicting development of cancer in
ulcerative colitis (GSE3629)
(Watanabe, Kobunai et al.
2007)
Human/Colon 121 MAS5
Human breast tumor expression (GSE3744)
(Richardson, Wang et al.
2006; Alimonti, Carracedo
et al. 2010)
Human/Breast 47 RMA
Expression profiling in early onset colorectal cancer
(GSE4107)
(Hong, Ho et al. 2007) Human/Colon 22 RMA
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Inflammation, adenoma and cancer: objective classification of
colon biopsy specimens with gene expression signature
(GSE4183)
(Gyorffy, Molnar et al.
2009; Galamb, Spisak et
al. 2010)
Human/Colon 53 RMA
Gene expression signature of colorectal cancer with
microsatellite instability (GSE4554)
(Watanabe, Kobunai et al.
2006)
Human/Colon 84 MAS5
Analysis of microdissected invasive lobular and ductal breast
carcinomas in relation to normal ductal and lobular cells
(GSE5764)
(Turashvili, Bouchal et al.
2007)
Human/Breast 30 RMA
Expression data from human breast tissue (GSE7904)
(Richardson, Wang et al.
2006)
Human/Breast 62 RMA
Transcriptome profile of human colorectal adenomas.
(GSE8671)
(Sabates-Bellver, Van der
Flier et al. 2007)
Human/Colon 64 RMA
embryo (GSE4201)
(Giraldez, Mishima et al.
2006)
Zebrafish/Embryo 15 RMA
heart (GSE4989)
(Marques, Leito et al.
2008)
Zebrafish/Hearth 10 RMA
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endothelial (GSE12039) (Fish, Santoro et al. 2008) Zebrfish/Embryo 12 RMA
nerve (GSE11493)
(MacInnes, Amsterdam et
al. 2008)
Zebrafish/Nerve 11 RMA
brain (GSE11107)
(Drew, Rodnick et al.
2008)
Zebrafish/Brain 8 RMA
liver (GSE11107)
(Drew, Rodnick et al.
2008)
Zebrafish/Brain 10 RMA
fin (GSE10188)
(Mathew, Sengupta et al.
2009)
Zebrafish/Fin 24 RMA
fin (GSE10184)
(Mathew, Sengupta et al.
2008)
Zebrafish/Fin 12 RMA
heart (GSE9020) (Chen, Carney et al. 2008) Zebrafish/Hearth 48 RMA
embryo (GSE9020) (Chen, Carney et al. 2008) Zebrafish/Hearth 48 RMA
retina (GSE8874) (Chen, Carney et al. 2008) Zebrafish/Retina 24 RMA
embryo (GSE8874) (Chen, Carney et al. 2008) Zebrafish/Retina 24 RMA
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liver (GSE8856)
(Robison, Drew et al.
2008)
Zebrafish/Liver 17 RMA
embryo (GSE8428)
(Maves, Waskiewicz et al.
2007)
Zebrafish/Embryo 12 RMA
larvae (GSE8327)
(Volkman, Pozos et al.
2010)
Zebrafish/Embryo 9 RMA
embryo (GSE7658) Zebrafish/Embryo 8 RMA
embryo (GSE6127) Zebrafish/Embryo 6 RMA
retina (GSE5048) (Leung, Ma et al. 2007) Zebrafish/Ovary 8 RMA
ovary (GSE4859)
(Heiden, Struble et al.
2008)
RMA
Expression data from human normal pre-frontal cortex, liver,
and colon tissues and colon tumors (GSE13471)
(Irizarry, Ladd-Acosta et
al. 2009)
Human/Colon 13 RMA
Expression data from primary colorectal cancers (GSE13067)
(Jorissen, Lipton et al.
2008)
Human/Colon 74 RMA
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Expression data from primary colorectal cancers (GSE13294)
(Jorissen, Lipton et al.
2008)
Human/Colon 155 RMA
Expression data from human colonic biopsy sample
(GSE10714)
(Galamb, Sipos et al. 2008;
Galamb, Spisak et al.
2010)
Human/Colon 33 RMA
Expression data of hormone-responsive MCF-7 cells versus
estrogen-deprived MCF-7:5C and MCF-7:2A breast cancer
cells (GSE10879)
Human/Breast 11 RMA
Timecourse of estradiol (10nM) exposure in MCF7 breast
cancer cells. (GSE11352)
(Lin, Vega et al. 2007) Human/Breast 18 RMA
Crosstalk between Estrogen and TNFalpha in MCF-7 Breast
Cancer Cells (GSE11467)
(Frasor, Weaver et al.
2009)
Human/Breast 12 RMA
Estrogen- and Myc-regulated genes in MCF-7 breast cancer
cells (GSE11791)
(Musgrove, Sergio et al.
2008)
Human/Breast 15 RMA
Transcription profiling of brain from zebrafish treated with
ethanol or nicotine suggests conservation of neuro-adaptation
(Kily, Cowe et al. 2008) Zebrafish/Brain 7 RMA
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pathways (EMEXP1301)
Transcription profiling of zebrafish ZF4 and PAC2 cell lines
cultured in medium with or without FCS (EMEXP736)
(He, Salas-Vidal et al.
2006)
Zebrafish/Fibroblast 9 RMA
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